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Abstract
Since most of human diseases are related to genetic mutations, during the past two decades,
identification of such mutations has attracted much attention. Detection of these mutations is
mainly based on hybridization with the complementary reporter probes.
Nucleic acid detection takes place by changing either the reporter’s fluorescence intensity or
the colour of its fluorescence. The use of fluorescent probes for nucleic acid detection has
attracted much attention due to its efficiency, the ease of synthesis and availability of
commercial reporters that facilitate the probe synthesis. Nowadays, most of nucleic acid
detection using fluorescent probes relies on quenching of fluorescence by energy transfer
from one fluorophore to another or to a nonfluorescent molecule (quencher). The most
common, widely used, quencher in fluorescent probes is 4-(N,N-dimethylamino)azobenzene4'-carboxylic acid (DABCYL).
The goal of this thesis was to introduce new quenchers which structurally mimic the
universal quencher DABCYL into peptide nucleic acid (PNA), DNA and RNA probes. These
quenchers are also characterized by their ability to undergo photoisomerization upon
illumination with light.
Chapter 2 describes the synthesis of a novel azobenzene-PNA quencher; incorporation of the
PNA quencher into PNA-molecular beacon probe and demonstration of efficient quenching
ability upon hybridization with the complementary DNA sequence.
Chapter 3 describes the synthesis of a new modified azo-based uracil PNA monomer and
evaluation of its quenching ability by incorporation of the PNA monomer in a dual peptide
sequence that is amenable to enzymatic degradation. The modified azo-based uracil moiety
has shown the ability to quench the fluorescein emission; upon enzymatic cleavage of the
peptide, fluorescent signal was recovered.
Chapter 4, based on the proven quenching ability of the modified azo-based uracil, this
modification was introduced into deoxyribo- and ribonucleosides. The photoisomerization
and halochromic behavior has been investigated on the synthesized compounds.
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The advantages of this nucleobase modification are: 1) introduction of novel quencher, 2)
potential duplex stabilization by retaining the ability of formation of hydrogen bond between
the modified nucleobase and the complementary nucleobase, 3) potential photoregulation
ability of azo-based modified nucleobase containing oilgomers with responding to incident
light.
Chapter 5 describes the synthesis of modified acridine-based uracil PNA monomer and
evaluation of its fluorescence property.

Keywords
Dimethylaminoazobenzene, peptide nucleic acid PNA, DNA, photochromic nucleosides,
quencher, fluorescent probes and acridine

iv

Acknowledgments
First of all, I thank God almighty for giving me the courage, strength and ability to continue
my graduate studies and finish this dissertation with all kind of stress, pressure and
difficulties that I faced throughout my study period.
I would like to express my deep gratitude and thanks to my supervisor Prof. Hudson for his
encouragement, scholastic guidance, suggestions and improving my presentation skills
through giving me the opportunity to attend many conferences. Thanks Dr. Hudson
I want to express my deep thanks and appreciation to my country Egypt for the financial
support that gave me the opportunity to be here in Canada to learn and develop my research
skills, thanks Egypt.
I would like to thank lab members past and present for their friendship. Dr. Fil, Dr. Dave
Mark, André, Kirby, Mojmir, Melissa, McKenry and Adam. Special thanks to Mark and
André for helping me to run mass analysis for my oligomer samples. Kirby and McKenry,
thanks for the sense of humor environment that you have spread at the lab. I love you all.
I would like to thank my committee members for taking the time to read my thesis and their
helpful discussions and guidance through my thesis preparation.
Last but not least, during my study period there was a lot of struggling, stress, depression,
difficult times and challenges. Certainly this work never be done without support that I had
from my beloved wife Amira and my kids Ahmed, Youssef and Adam. Special thanks to my
soul mate my wife Amira for her love and well taking care of our kids (huge
responsibility!!!). I want to thank my father and my mother for their support even they are in
Egypt, but they were so supportive to continue my doctoral studies. I knew that all of you
had difficult and lonely times, really I appreciate what all of you have done to me and I wish
I can make you up. Thanks my lovely family.

v

Dedication

To My lovely family
Wife Amira
Sons, Ahmed, Youssef and Adam

vi

Table of Contents
CERTIFICATE OF EXAMINATION ............................................................................... ii
Acknowledgments .............................................................................................................. v
Dedication .......................................................................................................................... vi
Table of Contents .............................................................................................................. vii
List of Tables ..................................................................................................................... xi
List of Figures ................................................................................................................... xii
List of Schemes ............................................................................................................... xvii
List of Abbreviations ..................................................................................................... xviii
CHAPTER 1 ....................................................................................................................... 1
AZOBENZENE AND ITS APPLICATION IN NUCLEIC ACID CHEMISTRY ............ 1
1.1 Nucleic acid overview ............................................................................................ 1
1.2 Automated DNA synthesis ..................................................................................... 3
1.3 Control of DNA’s functions by light ...................................................................... 6
1.4 Azobenezene ........................................................................................................... 8
1.4.1

The UV/Vis spectroscopy of azobenzene ................................................... 8

1.4.2

Photoisomerization of azobenzene ........................................................... 10

1.4.3

Utility of azobenzene as quencher ............................................................ 13

1.4.4

Some of biological applications based on azobenzene photoswitching ... 14

1.4.5

Photoregulation of enzymatic activities by azobenzene ........................... 17

1.4.6

New properties of azobenzene .................................................................. 20

1.5 Goal of this thesis..……………………………………………………………….22
1.6 References ............................................................................................................. 23
Chapter 2 ......................................................................................................................... 30
SYNTHESIS AND PHOTOPHYSICAL STUDIES OF AZO-BASED QUENCHER
FOR PNA-MOLECULAR BEACON ...................................................................... 30
vii

2.1 Fluorescence ......................................................................................................... 30
2.2 Fluorescence resonance energy transfer (FRET) theory and fluorescent
hybridization probes a ........................................................................................... 31
2.2.1

Examples of fluorescent hybridization probes using FRET mechanism .. 33

2.3 Peptide nucleic acid (PNA)................................................................................... 37
2.3.1

PNA binding modes with nucleic acids (NAs) ......................................... 38

2.3.2

PNA modifications ................................................................................... 41

2.3.3

Synthesis of PNA oligomers ..................................................................... 42

2.4 PNA applications .................................................................................................. 48
2.5 Results and discussion .......................................................................................... 49
2.5.1

Synthesis of the backbone......................................................................... 50

2.5.2

Synthesis of the dimethylaminoazobenzene PNA monomer .................... 51

2.5.3

Photoisomerization studies ....................................................................... 52

2.5.4

Effect of acid on dimethylaminoazobenzene PNA monomer .................. 51

2.5.5

Quenching ability of dimethylaminoazobenzene PNA monomer ............ 52

2.5.6

Design and synthesis of dual-labeled PNA molecular beacon ................. 56

2.6 Conclusion ............................................................................................................ 59
2.7 Experimental ......................................................................................................... 60
2.8 References ............................................................................................................. 65
CHAPTER 3 .................................................................................................................... 72
SYNTHESIS AND PHOTOPHYSICAL STUDIES OF NOVEL QUENCHER FOR
PNA ............................................................................................................................. 72
3.1 Introduction ........................................................................................................... 72
3.2 Results and discussion .......................................................................................... 73
3.2.1

Photoisomerization of azo-based uracil derivative and solvent effect on its
absorption spectrum .................................................................................. 75

3.2.2

pH-Sensitivity of azo-based uracil ........................................................... 76
viii

3.2.3

Design and synthesis of dual peptide for quenching study....................... 81

3.3 Conclusion ............................................................................................................ 87
3.4 Experimental ......................................................................................................... 88
3.5 References ............................................................................................................. 94
CHAPTER 4 .................................................................................................................... 97
SYNTHESIS AND PHOTOPHYSICAL STUDIES OF NOVEL PHOTOCHROMIC
PHOSPHORAMIDITE FOR DNA AND RNA ....................................................... 97
4.1 Introduction ........................................................................................................... 97
4.2 Result and discussion ............................................................................................ 99
4.2.1

Photoisomerization studies ..................................................................... 101

4.2.2

pH-Sensitivity ......................................................................................... 103

4.3 Conclusion .......................................................................................................... 105
4.4 Experimental ....................................................................................................... 106
4.5 References ........................................................................................................... 112
CHAPTER 5 .................................................................................................................. 115
SYNTHESIS OF ACRIDINE-BASED PNA MONOMER SUITABLE FOR PNAFLUORESCENT PROBES..................................................................................... 115
5.1 Hydrogen bonding .............................................................................................. 115
5.2 Base-stacking ...................................................................................................... 116
5.3 Fluorescent nucleobases ..................................................................................... 117
5.4 Acridine .............................................................................................................. 121
5.5 Results and discussion ........................................................................................ 123
5.5.1

Photophysical properties ......................................................................... 124

5.5.2

Fluorescence properties of acridine-based monomer ............................. 125

5.5.3

Future work ............................................................................................. 125

5.5.4

Conclusion .............................................................................................. 125

5.6 Experimental ....................................................................................................... 126
ix

5.7 References ... ……………………………………………………………………130
CHAPTER 6 ……………………………..…………………………………………...136
FUTURE OUTLOOK…………………….……………………………………..........136
APENDICES (Selected NMR and MS spectra) ............................................................ 138
CURRICULUM VITAE .............................................................................................. 158

x

List of Tables
Table 2-1: Melting Temperature ............................................................................................ 59
Table 3-1: Selected bond distances (Å) and angles (°) for III-2 ............................................ 74
Table 3-2: Maximum absorption wavelength and molar extinction coefficient of III-3 ....... 75
Table 3-3: Effect of addition of 3 mM HCl on absorption maximum wavelength (max) of
III-3...................................................................................................................... 77
Table 3-4: X-ray crystallographic structural parameters for compound III-2. ..................... 92
Table 5-1: Photophysical properties of V-6 ......................................................................... 124

xi

List of Figures
Figure 1-1: The central dogma of molecular biology. ............................................................. 2
Figure 1-2: Watson-Crick base pairing between T:A and G:C…. ........................................... 3
Figure 1-3: DNA duplex structure. .......................................................................................... 3
Figure 1-4: Composition of commercial available phosphoramidite monomers. .................... 4
Figure 1-5: Traditional solid-phase phosphoramidite oligonucleotide synthesis cycle. .......... 5
Figure 1-6: Release of the oligomer from the universal support by NH4OH .......................... 6
Figure 1-7: Photocleavable moieties for photoregulation of biological activity. .................... 7
Figure 1-8: Different classes of photochromic molecules. ...................................................... 8
Figure 1-9: Different examples of azobenzenes. ..................................................................... 9
Figure 1-10: a) Molecular orbital diagram for azobenzene system, b) UV-Vis spectrum of
azobenzene in ethanol at room temperature........................................................ 9
Figure 1-11: Photoisomerization of azobenzene in response with UV/Vis light. .................. 10
Figure 1-12: Excitation and relaxation routes of trans and cis azobenzene isomer. ............. 11
Figure 1-13: The proposed mechanisms for the isomerization of trans to cis azobenzene. .. 12
Figure 1-14: Proposed mechanism for cis to trans thermal isomerisation in azobenzene .... 13
Figure 1-15: Structure of the universal quencher DABCYL. ................................................ 14
Figure 1-16: Photoisomerization azobenzene-based cyclic peptides………………………..16
Figure 1-17: Structure of azobenzene monomer used in photoregulation of DNA. .............. 18
Figure 1-18: Photoswitching of transcription using T7 RNA polymerase. ........................... 19
xii

Figure 1-19: Photoregulation of RNase H activity. ............................................................... 20
Figure 1-20: Fluorescent azobenzene due to B-N interaction................................................ 21
Figure 1-21: Bridged azobenzene .......................................................................................... 21
Figure 2-1: Jablonski diagram illustrated luminescence origin. ............................................ 31
Figure 2-2: Resonance energy transfer Jablonski diagram and spectral overlap donor
emission spectra with acceptor absorption spectra. ............................................ 33
Figure 2-3: Schematic representation for adjacent probes. .................................................... 33
Figure 2-4: Schematic representation for 5`-nuclease probes. ............................................... 34
Figure 2-5: Schematic representation for strand-displacement probes. ................................. 34
Figure 2-6 : Schematic representation for molecular beacon. ............................................... 35
Figure 2-7: Examples of fluorophores and quenchers have been used in fluorescent ........... 36
Figure 2-8: Comparison between DNA and PNA structures. ................................................ 38
Figure 2-9: Binding modes of PNA with double-stranded DNA........................................... 39
Figure 2-10: Triplex invasion of double helix DNA by homopyrimidine PNA oligomers. . 40
Figure 2-11: Double duplex invasion of DNA by pseudo complementary PNAs. ................ 41
Figure 2-12: Selected examples of modified PNA backbone. ............................................... 42
Figure 2-13: Selected examples of modified PNA nucleobases. ........................................... 42
Figure 2-14: Side reactions in PNA synthesis………………………………………………44
Figure 2-15: Structures of commercially available tBoc/Z PNA monomers…….………

46

Figure 2-16: Structures of commercially available Fmoc/Bhoc monomers. ......................... 46
Figure 2-17: General strategy for solid phase peptide nucleic acid synthesis...…………….46
xiii

Figure 2-18: Examples of various protecting groups in PNA synthesis.. .............................. 47
Figure 2-19: Comparison between the structure of GPNA and aeg-PNA. ............................ 49
Figure 2-20: Changes in the UV-Vis absorption spectrum of II-5 in EtOH.......................... 53
Figure 2-21: UV-Vis spectral change of II-5 in dichloromethane......................................... 52
Figure 2-22: The effect of increasing amounts of II-5 on the emission spectra of A)
fluorescein and B) pyrene.. ............................................................................... 55
Figure 2-23: The effect of increasing amounts of II-5 on the fluorescence emission spectra
of sulforhodamine 640 dye. ......................................................................... 55
Figure 2-24: Structures of the fluorophores have been used in the study. ............................. 56
Figure 2-25: Mass spectrum of azo-based PNA oligomer II-6. ............................................ 57
Figure 2-26: Mass spectrum of PNA-MB II-7. ..................................................................... 57
Figure 2-27: Fluorescence emission spectra of 4-(N,N-dimethylamino)azobenzene based
PNA-MB and PNA-MB-cDNA ....................................................................... 58
Figure 2-28: Schematic representation for formation of triplex PNA2:DNA ....................... 59
Figure 3-1: Examples of azo-based PNA monomers. ............................................................ 72
Figure 3-2: Similarity in structure between DABCYL and the modified uracil .................... 73
Figure 3-3: The X-ray crystal structure of III-4. ................................................................... 74
Figure 3-4: Photoisomerization of 4-(N,N-dimethylamino)phenylazouracil derivatives. ..... 75
Figure 3-5: Absorption spectrum of III-3 in CH3CN. ........................................................... 76
Figure 3-6: Schematic representation of azonium and ammonium ions. ............................... 76
Figure 3-7: Spectral change of III-3 in CH3COCH3.............................................................. 77
Figure 3-8: Effect of TFA on III-3 in a) CH3CN, b) in EtOH............................................... 78
xiv

Figure 3-9: Compound III-3 in a) various solvents, b) after addition of TFA., c) after
basification. ......................................................................................................... 79
Figure 3-10: Compound III-3 in CH2Cl2 with haloacids. ...................................................... 79
Figure 3-11: Fluorescence changes of 8 M fluorescein upon addition of various amount of
III-3 in EtOH .................................................................................................... 80
Figure 3-12: Fluorescence spectra of 5 M concentration of pyrene in ethanol recorded upon
addition of varied amount of III-3 in EtOH ..................................................... 80
Figure 3-13: Schematic representation on the mechanism of FRET-Peptide. ....................... 81
Figure 3-14: Designed FRET Peptide having azo-based PNA monomer as quencher and
FITC as fluorophore. ........................................................................................ 82
Figure 3-15: UV-Vis spectra of FRET-Peptide ..................................................................... 84
Figure 3-16: Schematic representation of the modified dual labelled peptide design. .......... 84
Figure 3-17: Fluorescence emission spectrum of dual peptide ............................................. 85
Figure 3-18: Mass spectrum of FRET-peptide ...................................................................... 86
Figure 3-19: Mass spectrum of FRET-peptide after digestion .............................................. 86
Figure 4-1: Modified oligonucleotides carrying azobenzene a) in the side chain, b) as
linker……………………................................................................................. 98
Figure 4-2: Schematic representation of trans-cis photoisomerization of IV-2 and IV-6 .. 101
Figure 4-3: Absorption spectra of A) IV-2 in CH2Cl2, B) IV-6 in CH3CN ....................... 102
Figure 4-4: Structure of 4-(N,N-dimethylaminoazo)phenyl(deoxy)uridine and its protonated
forms ................................................................................................................. 103
Figure 4-5: Changes in UV-Vis spectra of A) IV-2 and C) IV-6 upon addition of increasing
concentrations of TFA. .................................................................................... 105
xv

Figure 5-1: Base pairing between DAP:T comparing to A:T .............................................. 115
Figure 5-2: Hybridization of cytosine and its modification moPhpC with guanine ............ 116
Figure 5-3:Represntation of hybridization of 2AP with thymine and cytosine ................... 118
Figure 5-4: Strcuture of some pteridine derivatives............................................................. 118
Figure 5-5: Examples of expanded nucleobases. ................................................................. 119
Figure 5-6: Examples of hydrocarbons and heterocyle DNA base replacement. ................ 120
Figure 5-7: Structures of some conjugated base analogues used in DNA and RNA probes
............................................................................................................................................... 121
Figure 5-8: Structure of acridine, m-AMSA and acridine orange (AO). ............................. 122
Figure 5-9: UV-Vis spectrum of V-6 in neutral and acidic form......................................... 124
Figure 6-1: Structures of phenylazo derivatives .................................................................. 136
Figure 6-2: Structures of azo-based uracil derivatives......................................................... 137

xvi

List of Schemes
Scheme 2-1: Synthesis of 2-Fmoc(aeg)-t-butyl ester backbone............................................. 50
Scheme 2-2: Synthesis of azo-based PNA monomer. ............................................................ 51
Scheme 2-3: Ammonium/azonium protonated ions of 4-(N,N-dimethylamino)azobenzene. 52
Scheme 3-1: Synthesis of 4-(N,N-dimethylamino)phenylazouracil PNA monomer.............. 73
Scheme 3-2: Degradation mechanism of FITC labelled peptide by the effect of TFA…….. 83
Scheme 4-1: Synthesis of phosphoramidite possesses phenylazo moiety for photoswitching
............................................................................................................................................... 100
Scheme 4-2: Synthesis of photochromic riboside. ............................................................... 101
Scheme 5-1: Synthesis of acridine-based PNA monomer V-6. ........................................... 123

xvii

List of Abbreviations
A
ADP
aeg
EDANS
Bhoc
BSA
calc.
ROX
Cat D

CD
cDNA
CPG
J
C
°C
dA
dC
dG
DNA
dT
DCC
DCU
DIEA
DMF
DMT
DMSO
DAN

Dde
JOE
DMTCl
DABCYL
DCA
d
ESI
EtOH
EDTA
Fmoc
FITC

adenine
adenosine diphosphate
aminoethylglycine
5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid
benzhydryloxycarbonyl
bovine serum albumin
calculated
6-carboxy-x-rhodamine
cathepsin d
chemical shift in parts per million downfield from tetramethylsilane
circular dichroism
complementary deoxyribonucleic acid
controlled-pore glass
coupling constant in Hz
cytosine
degrees Celsius
deoxyadenosine
deoxycytosine
deoxyguanosine
deoxyribonucelic acid
deoxythymidine
dicyclohexyl carbodiimide
N,N-dicyclohexylurea
N,N-diisopropylethylamine
N,N-dimethylformamide

4,4-dimethoxytrityl
dimethyl sulfoxide
dimethylamino-2-acylnapthalene

1-(4,4-dimethyl-2,6-dioxacyclohexyl)ethylidene
2',7'-dimethoxy-4',5'-dichloro-6-carboxyfluorescein
4,4'-dimethoxytrityl chloride
4-(N,N-dimethylamino)azobenzene- 4'-carboxylic acid
dodecylammonium chloride
Doublet
electrospray ionization
Ethanol
ethylenediaminetetraacetic acid disodium
fluorenylmethyoxycarbonyl
fluorescein isocyanate
xviii

FISH
F
FRET
Fmoc-OSu
FDA
G
HF
HRMS
HOBt
MALDI-TOF
mRNA
MB
MmT
m
NVOC
ONs
ONB
PNAs
PSS
PCR
RP-HPLC
RNA
RNAP
SNPs
s
tBoc
THF
T
tRNA
TAMRA
EtN3
TLC
TFA
TFMSA
TMP
TMS
t
Trp
UV
U
Vis


fluorescence in situ hybridization
fluorescence quantum yield
fluorescence resonance energy transfer
N-(9-fluorenylmethoxycarbonyloxy) succinimide
food and drug administration
guanine
hydrogen fluoride
high resolution mass spectrometry
N-hydroxybenzotriazole

matrix assisted laser desorption-ionization time-of -flight
messenger ribonucleic acid
molecular beacon
monomethoxytrityl group
multiplet
nitroveratryloxycarbonyl
oligonuclotides
ortho-nitrobenzyl
peptide nucleic acids
photostationary phase
polymerase chain reaction
revered phase high pressure liquid chromatography
ribonucelic acid
RNA polymerase
single-nucleotide polymorphisms
singlet
tert-butyloxycarbonyl
tetrahydrofuran
thymine
transfer ribonucleic acid
N,N,N',N'-tetramethyl-6-carboxyrhodamine
triethylamine
thin layer chromatography
trifluoroacetic acid
trifluoromethane sulphonic acid
trimethyl phosphate
trimethylsilyl
triplet
tryptophane
ultra violet
uracil
visible
wavelength
xix

Chapter 1

xx

1

Chapter 1
1

Azobenzene and Its Application in Nucleic Acid Chemistry
1.1

Nucleic acid overview

Since the discovery of the three dimensional structure of DNA double-helix in 1953 by
Watson and Crick,1 nucleic acids have been recognized as key components of life. This
discovery encouraged many scientists to devote effort to explore the emerging science of
molecular biology. Without a doubt, all living organisms need to reproduce. To ensure
the continuation of their species, genetic information must be transferred from
a generation to the next. This idea led scientists to question how these biological
processes took place.
In 1958, Francis Crick2 was the first to propose the concept of the central dogma of
molecular biology. Simply, it describes the flow of information via biological processes
involving transcription of DNA to RNA which is then translated to protein. Protein is
never back-translated to RNA or DNA, DNA is never created from RNA except in case
of retroviruses. Furthermore, DNA is never directly translated to protein.
As shown in (Fig.1-1), the central dogma of molecular biology is represented in three
stages: Firstly, replication of DNA which involves the copying of DNA. Secondly,
transcription involves the formation of mRNA, a single stranded ribonucleic acid that
carries the genetic code from the DNA in the nucleus to the sites of protein synthesis in
the cytoplasm. Thirdly, translation of mRNA to proteins which are responsible to perform
all of the body's essential functions as growth, repair, metabolizing food, fighting
infections and much more.
If a mutation occurs in a gene, this can lead to production of a completely distorted
protein that is unable to carry out its function or it may change the amount of a protein
being produced. To control the effect of mutations, unique strategies were established
based on oligonuclotides (ONs) namely antigene and antisense. In the antigene strategy,
nucleic acid analogues are designed to recognize and bind to the complementary
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sequence in a particular gene (DNA) and thereby interfere with the transcription of that
particular gene (thus inhibit the formation of mRNA). While in the antisense strategy the
nucleic acid analogues are designed to recognize and hybridize to a complementary
sequence in mRNA and thereby stop its translation to protein and therefore effectively
turn that gene "off".

Figure 1-1: The central dogma of molecular biology. Adapted from
http://www.accessexcellence.org /RC/VL/GG/central.php.
Oligonucleotides have also been shown to be of particular value as diagnostic agents that
are easily labeled with reporter groups as fluorophores and bind with its complementary
nucleic acids with high and specific affinities.
Hybridization between nucleic acids to form DNA:DNA or DNA:RNA duplexes is
ascribed to the specific binding between the nitrogenous nucleobases in each strand. It is
known that guanine (G) pairs with cytosine (C) and thymine (T)/(uracil (U) in case of
RNA) pairs with adenine (A) via the hydrogen bonding interactions shown in (Fig. 1-2).
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Figure 1-2: Watson-Crick base pairing between A: T and G:C.
A typical DNA duplex is formed by two strands that run in opposite directions to yield a
helical structure (Fig. 1-3). These strands are composed of deoxynucleosides dA, dC, dG
and dT which is connected together via negatively charged phosphate groups. The
stability of the DNA duplex is determined by the composition of the DNA sequence and
the ionic conditions of the aqueous environment.

Figure 1-3: DNA duplex structure.

1.2

Automated DNA synthesis

Nucleic acids are naturally synthesized within the biological environment via
bioreactions that are catalyzed by enzymes. However, there is a huge need for millions of
DNA assays to be able to examine antigene and antisense probes. Currently, nucleic acids
can be synthesized in laboratory with sequences similar to the naturally occurring DNA
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strands. In addition, synthesis of DNA strands bearing chemically modified nucleobases
that possess novel functions and unique properties is possible. This innovation leads to
production of numerous DNA oligonucleotides with potential biological applications.
Currently, a well established methodology called solid support synthesis of oligonucleotides3 is widely used for the synthesis of DNA sequences using an automated
instrument, the DNA synthesizer. This technique is extremely useful because it
provides a rapid and inexpensive access to custom-made oligonucleotides of the desired
sequence. The phosphoramidite protocol is the most common strategy for DNA
synthesis, this protocol is characterized by using nucleotide phosphoramidite units
bearing different bases as illustrated in (Fig. 1-4). Each phosphoramidites is composed of
nucleobase with suitable protecting group for the exocyclic amine, deoxyribo sugar with
dimethoxytrityl (DMT) group protect the 5`-OH and phosphate with diisopropylamine
and 2-cyanoethyl groups which are very essential to order the synthesis direction.

Figure 1-4: Composition of commercial available phosphoramidite monomers.
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Automated DNA synthesis is carried out by using controlled-pore glass (CPG) support,
the phosporamidite with the different nucleobases are loaded into the commercially
available DNA synthesizer and simply by choosing the desired DNA sequence through a
program, the synthesis can be achieved in few hours based on the length of the DNA
sequence. As illustrated in (Fig. 1-5), the DNA synthesis cycle consists of four stages
namely detritylation, coupling, capping and oxidation. For every synthesis cycle, one
nucleotide is added at a time for the growing oligonucleotide through the four steps until
the desired sequence is built. In fact, the desired sequence may be accompanied with
undesired oligonuclotide species in different length due to incomplete synthesis during
the process. After synthesis completion, the oligonucleotide is released from the support
under basic conditions, generally with ammonium hydroxide, is purified by reversedphase high pressure liquid chromatography (RP-HPLC) to afford the desired sequence.
The pathway to release the oligonucleotide from the solid support is shown in (Fig. 1-6).

Figure 1-5: Traditional solid-phase phosphoramidite oligonucleotide synthesis cycle.
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Figure 1-6: Release of the oligomer from the universal support by NH4OH.
Although the utility of the phosphoramidite methodology for oligonucleotide synthesis
for several biological uses is satisfactory, its usage for production of large-scale
oligonucleotide synthesis was accompanied with side-reactions, which were tolerated in
small-scale synthesis. These side reactions are depurination of protected bases due to
repetitive acid treatment at detritylation step, and missing one or more of the correct
nucleotides in the desired sequence by the effect of acid treatment leading to formation of
sequences with mutations; thusly, the presence of such mutations limits its applications.

1.3

Control of DNA’s functions by light

There exists a large effort directed to develop biomolecular tools to control biological
processes using external stimuli. Over the last two decades several external stimuli were
investigated to regulate the replication, transcription and translation processes of genes.
Amongst the variety of stimuli such as light, pH, electric field and heat, light is the most
promising. This is due to many reasons such as using light is efficient, clean and does not
produce any contaminants that could affect the biological system and the facile synthesis
of various photoresponsive molecules which provide a wide range of excitation
wavelengths.
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Photoresponsive molecules are defined as molecules that undergo predictable changes in
response to light. They are classified as photocleavable and photoswitchable molecules,
also known as photochromic molecules. Examples of photocleavable moieties are
hydroxylphenylacyl, coumarin and o-nitrobenzyl derivatives (Fig. 1-7). o-Nitrobenzyl
derivatives have been widely used due to its stability in synthetic and biological
environments. Because the photocleavable processes are irreversible, photoswitchable
molecules are preferable. Photochromic molecules are molecules that undergo structural
rearrangement between two or more isomeric forms in response to irradiation. The
direction of this arrangement is determined by the wavelength of the incident light.

Figure 1-7: Photocleavable moieties for photoregulation of biological activity.
There are several classes of photochromic molecules as azobenzenes, stilbenes,4
diarylethenes,5 thioindigo derivatives,6 fulgides7 and spiropyrans.8 The structures are
illustrated in (Fig. 1-8). In all cases, the photoisomerization process is reversible; while
after repeated isomerization cycles a fatigue can set. In our work we are interested in
azobenzene as photochromic molecule.
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Figure 1-8: Different classes of photochromic molecules.

1.4

Azobenezene

Azobenzene, is an organic molecule consisting of two phenyl rings linked together with
azo group (N=N) in which each nitrogen atom carries a non-bonding pair of electrons.
Azobenzene was used for the first time in 1879,9a-b and initially was used as a dye. It is
currently employed in 60-70 % of the dye industry.10
Recently, the isomerization properties of azobenzenes were rediscovered and have been
exploited in many applications such as optical data storage,11 liquid crystal display,12
molecular machines design13 and many biochemical activities.14-a-b All these applications
are based on its ability to undergo geometrical trans-cis isomerization in response with
light.

1.4.1

The UV/Vis spectroscopy of azobenzene

To have a full understanding of the spectroscopy of azobenzene, knowledge of its excited
states is essential. Cis- and trans azobenzene have three excited single states attributed to
three absorption bands that appear in the visible and near UV regions as shown in (Fig. 110a and 1-10b).15a-b In the azobenzene system, there are three types of electronic
transitions: 1) The lowest-energy transition is that obtained due to the forbidden ns1*
transition which corresponds to the S0S1, this transition appears in the visible region at
approximately 430 nm and 440 nm for cis and trans isomers, respectively. 2) Transition
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that occurs due to symmetry-allowed 11* transition corresponding to the S0S2
which appears in the UV region at 280 nm and 314 nm for cis and trans isomers
respectively and 3) the highest-energy transition due to * transition that occurs at
the region 230-244 nm are for cis and trans isomers. The presence of an electron
donating substituent in ortho or para positions as (OH or NH2) to the azo group leads to
decrease the energy of -* transition and consequently the -* absorption band shifts
to longer wavelength. Generally, the greater the electron donating substituent the greater
the bathochromic shift. For example, the presence of dimethylamino group in para
position of azobenzene ring decreases the -* energy more than p-amino group and
thusly appearing at longer wavelength. Another example of azobenzene analogues is
pseudostilbene (Fig. 1-9), an azobenzene system which contains an electron donating and
electron accepting group in resonance at the para positions. The presence of the donating
and accepting groups leads to a reduction of the energy of -* transition and
consequently its appearance at longer wavelengths.

Figure 1-9: Different examples of azobenzenes and effect of substituents on the
absorption bands. D and A represent donor and acceptor groups substituted.
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1.4.2

Photoisomerization of azobenzene

Azobenzene can undergo geometrical structural change from trans to cis isomer, and
reverse, in response to optical excitation with light at suitable wavelength. As shown in
(Fig. 1-11), trans to cis isomerization takes place via excitation with UV light at
(300>>400 nm), while upon excitation of cis-form with visible light (> 400 nm), or
thermally, the trans isomer is recovered. The trans isomer is a conjugated planar
molecule and its  electrons can be delocalized over the entire molecule therefore it is
thermally stable while in the cis isomer there is a steric clash between the two phenyl
rings which forces the molecule to have a skewed conformation and consequently it is
less stable than the trans isomer. The trans-to-cis photoisomerization process is seen to
be accompanied by a structural change in which the distance between para carbon atoms
in azobezene decreased from 9Å in trans isomer to 5.5 Å in the cis isomer.16 This change
in geometry is the cornerstone for various azobenzene applications.

Figure 1-11: Photoisomerization of azobenzene in response with UV/Visible light.
As shown in (Fig. 1-12), after excitation of the trans isomer with light of suitable
wavelength, it will decay to either the ground state (S0) of trans or that of cis isomer.
Similarly, upon excitation of the cis isomer a relaxation to either the ground state (S0) of
cis or trans occurred. The decaying of the cis isomer may take place thermally to the
trans isomer. A photostationary state (PSS), an equilibrium state between the rates of
excitation and relaxation of the cis and trans isomers, can be reached when both cis and
trans isomer absorb radiation of the same frequency. Due to the absorbance spectra of
trans and cis azobenzene are quite different, the photoisomerization process can be
followed by UV/Vis spectroscopy. The ground state energy of trans isomer at room
temperature was found to be lower than the cis-azobenzene by an estimate 11.8-13.8
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kcal/mol.17a-b and the energy barrier to reach cis isomer was found to be 36.9 kcal/mol.18
Consequently, in the dark the more thermally stable trans isomer is found to
predominate.

Figure 1-12: Excitation and relaxation routes of trans and cis azobenzene isomer.

1.4.2.1

The photoisomerization mechanism

The mechanism of the photoisomerization of azobenzene has been a longstanding debate
in the literature. There are two proposed pathways for this process to take place either by
a rotation or inversion mechanism19a-e as illustrated in (Fig. 1-13). Rotation mechanism
involves a torsion of the N=N bond around the dihedral angle (, CN-NC), while
inversion mechanism involves an in-plane inversion of the angle () around the azo group
and one of the attached carbon of the benzene ring (NN-C). Despite the numerous reports
investigating the photoisomerization mechanisms of azobenzene, there has been no
agreement on which pathway the photoisomerization takes.
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Figure 1-13: The proposed mechanisms for the isomerization of trans to cis
azobenzene.

1.4.2.2

Thermal cis to trans isomerization.

Similar to the photoisomerization, the thermal isomerization cis to trans is agreed to take
place via rotation mechanism or inversion mechanism as shown in (Fig. 1-14). Although
both mechanisms are viable,20 more studies support the rotation mechanism.21a,b Thermal
isomerization of azobenzenes is dependent on various factors as solvent polarity,
substitution on the aromatic ring and pH of the medium. Subjecting azobenzene to acidic
condition catalyzes the thermal isomerization via formation of an azonium protonated
intermediate and thus the –bond of N=N is ruptured and consequently facilitates the
rotation around the N-N via rotation mechanism.22
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Figure 1-14: Proposed mechanism for cis to trans thermal isomerisation in
azobenzene adapted from ref. 21b

1.4.3

Utility of azobenzene as quencher

During the last two decades DNA detection has attracted much attention due to its
potential applications in disease treatment. The most common method for DNA
hybridization detection is molecular beacon technology23 (MB) which involves labeling
of DNA probes with fluorescent dyes and quenchers. This approach relies on the design
of the labeled probes.
One example of an azobenzene derivatives used as a quencher is p-aminoazobenzene. It
has been tested for quenching the fluorescence signal of Bovine Serum Albumin (BSA)
protein,24 a protein that responsible in the transport and disposition of endogenous and
exogenous compounds present in blood. It is known that BSA has two tryptophan
residues Trp-212 and Trp-314 which possess intrinsic fluorescence. At physiological pH,
it was found that the fluorescence intensity of BSA was quenched gradually with the
increase of p-aminoazobenzene concentrations accompanied with blue shift of the
maximum emission wavelength up to 7 nm.
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4-(N,N-Dimethylamino)azobenzene-4-carboxylic acid (DABCYL) is another example
of an azobenzene-based quencher (Fig.1-15). It is characterized by an absorption
maximum at 475 nm and it has quenching range from 400-550 nm. This property has
allowed its use to quench a wide range of common fluorescent dyes such as 5-((2'aminoethyl)amino)naphthalene-1-sulfonic acid (EDANS) (em= 490 nm), carboxyfluorescein (FAM) (em=520 nm), tetrachlorofluorescein (TET) (em= 535 nm), 2',7'dimethoxy-4',5'-dichloro-6-carboxyfluorescein (JOE)(em= 548 nm) and hexachlorofluorescein (HEX) (em= 550 nm). The quenching ability of DABCYL molecule was
intensively investigated in numerous biological systems with oligonucleotides (for
nucleic acid detection or peptide for monitoring enzymatic activity.25

Figure 1-15: Structure of the universal quencher DABCYL.

1.4.4

Some of biological applications based on azobenzene
photoswitching

Azobenzene has proven to be a useful tool for switching activities in biological systems.
This is mainly due to three reasons: azobenzene chemistry is well established,
photoisomerization of azobenzene is reversible and photoisomerization can easily be
achieved by shining light on the azobenzene-based biological system to be regulated.
Azobenzene photoregulation was extensively investigated in various biological systems
as peptides, enzymes, ion channels and oligonucleotides.

1.4.4.1

Photoregulation of peptides by azobenzene

Azobenzene derivatives were employed to photo-induce random/-helix transitions in
polypeptides. The first example of polypeptides containing photoisomerizable
azobenzene chromophore were reported by Goodman,26a,b who used phenylazophenyl
alanine for photoregulation of polypeptides.
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To follow the variation of polypeptide structures corresponding to the photoisomerization
of tethered azobenzene, circular dichroism (CD) was used. It was the most effective
technique since the various polypeptide structures, random coil, -helix and -structure
have a characteristic circular dichroism spectra. Pieroni and coworkers27a,b reported the
incorporation of azobenzene into the side chain of poly(L-glutamic acid). In organic
solvents as trifluoroethanol or trimethyl phosphate (TMP), the azo-based polypeptide has
been confirmed by CD to exist in -helix structure. Upon illumination at 350 nm to
produce trans-to-cis photoisomerization, no change in CD spectrum was observed. This
indicates, under these solvents, light does not induce any variation in the main-chain
structures. While in water at critical pH values,28 20% azo-modified poly(L-glutamic
acid) exhibited CD spectra attributed to random coil structure and upon irradiation no
change in the CD was observed. By the addition of surfactant dodecylammonium
chloride (DAC)27b at its critical micelle concentration, the CD spectrum confers the
random coil structure. Upon exposure to light at 350 nm, CD spectrum confirms
switching of the azo-modified polypeptide from random coil to up to 30% -helix
structure. A complete conversion from -helix to random coil transition was obtained by
irradiation of the sample at 450 nm or thermally in the dark.
The effect of trans-to-cis isomerization of azobenzene derivatives has been investigated
by photoinducing the helical sense of poly(L-aspartate).29a-c In 1,2-dichloroethane, the
poly(L-aspartate) with high content of azo units has been confirmed to exist in lefthanded helical structure and upon irradiation with uv-light at 350 nm, a transition to
right-handed helical structure was observed. It was found that using solvent mixtures as
1,2-dichloroethane: trimethyl phosphate (TMP) (75:25%) induces a large photoresponsive effect even at a low content of azo units.

Another example of photoregulation of cyclic peptide by azobenzene was reported by
Vollmer and coworkers,30 they designed a peptide system composed of two cyclic
octapeptides with alternating D- and L--amino acids linked by an azobenzene linker as
shown in (Fig. 1-16). Azobenzene is known to be exist in the more thermally stable trans
isomer and thus the peptides were assembled in high-order oligomers due to
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intermolecular hydrogen bonding between the peptides. Upon irradiation with UV light at
366 nm, a conversion from intermolecular assemblies into single intramolecular
hydrogen bonded species was observed due to trans-to-cis isomerization and recovery of
trans isomer was obtained via irradiation with visible light. The photoisomerization of
the azobenzene-based cyclopeptide was completely reversible in both directions.

Figure 1-16: Photoisomerization of azobenzene-based cyclic peptides. Upon UV
irradiation, a conversion from intermolecular assemblies (trans form) into single
intramolecular hydrogen bonded species (cis form) was obtained.
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1.4.5

Photoregulation of enzymatic activities by azobenzene

Azobenzene has been widely used for reversible switching by light between alternative
conformations of peptides and proteins. Different approaches have been used to introduce
azobenzene into peptides and proteins such as, incorporation during peptide synthesis,31a,b
incorporation during in vitro translation,32 incorporation in vivo by utilizing an
orthogonal tRNA/aminoacyltRNA synthetase pair (specific for phenylalanine-4`azobenzene33) and through chemical modification of peptides and proteins.34 Photoregulation of enzyme activities has been achieved for numerous kinds of enzymes as
phospholipase,33 papain, -chymotrypsin, RNase S.35
-Chymotrypsin and papain catalyze the cleavage of peptide bonds, controlling the
enzymatic acitivity of -chymotrypsin and papain by azobenzene was found to take place
in

different

mechanisms.

-Chymotrypsin36

activity

was

controlled

by

photoisomerization of azobenzene through immobilizing the -chymotrypsin inside
a copolymer matrix containing azobenzene moieties. In other words, there was no need to
directly attach azobenzene unit to the enzyme. Willner and coworkers37 have shown that
photocontrol of papain activity can be achieved in a different way, through
photoisomerization of covalently attached azobenzene moieties to the lysine residues in
the enzyme backbone. They believed that the photoisomerization of trans-azobenzene
units to cis isomers is accompanied with structural changes in the protein backbone and
consequently affects the binding properties of the enzyme toward the substrate.
Schierlinga and coworkers38 were able to control the activity of restriction enzyme PvuII
for gene targeting DNA genome at specific sites in vivo. To accomplish this purpose,
4,4`-bis(maleimido)azobenzene has been used as azobenzene analogue. Azobenzene
moieties were attached through two cysteine residues between the two halves of the
enzyme PvuII and thereby cross-linking them. Upon illumination with blue light (450
nm), an increase in DNA cleavage activity up to 16 fold was observed by changing the
configuration of azobenzene units from cis to trans.
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1.4.5.1

Incorporation of azobenzene to oligonucleotides

The first example of reversibly photoswitchable oligonucleotides was introduced by
Yamana and co-workers.39a,b They were able to bind two oligonucleotides via azobenzene
as a linker, upon irradiation with light at around 350 nm the azobenzene linkers
efficiently undergo trans-to-cis isomerization. Later, Komiyama’s group incorporated
azobenzene (Fig. 1-17) to the side chain of DNA oligonucleotides using phosphoramidite
chemistry. In this study, a short DNA oligomer was synthesized (homothymidine-8mer)
whereas azobenzene was introduced as a replacement of one nucleoside. In case of trans
isomer, the melting temperature between the azobenzene containing homothymidine and
homoadenosine was found to be slightly different from that between unmodified
homothymidine and homoadenosine by 0.9 C. Upon photoisomerization to cis isomer, a
reduction of 8.9 C in the melting curve was observed. On the basis of these results
Komiyama investigated the ability of azobenzene-photoizomerization on the regulation
of DNA duplex40 and triplex.41

Figure 1-17: Structure of azobenzene monomer used in photoregulation of DNA.

1.4.5.1.1

Photoregulation of DNA transcription by azobenzene

Asanuma and coworkers42 were able to utilize azobenzene in photoregulation of the
transcription through controlling T7 RNA polymerase reaction (T7 RNAP). At the first
study, a 20-mer containing the azobenzene residue at different locations as an insertion
without replacement of any nucleotide was synthesized and a 39-mer was used to form
the double stranded T7 promoter (Fig. 1-18). It was found that upon illumination with
visible light, the azobenzene units exist in the trans isomer, the transcription rate was
suppressed by 10% relative to the control reaction. While by irradiation with UV light the
cis isomer was generated and consequently the transcription rate was increased. They
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explained the effect of trans to cis photoisomerization on the transcription by that when
azobenzene exist as trans configuration can intercalate between the DNA double strands
and thus maintain the DNA duplex. By switching trans to cis isomer, the azobenzene
disturbed the DNA duplex and thus facilitates the transcription reaction. The regulation
of transcription was found to be dependent on the azobenzene unit location. The highest
efficiency of transcription photoregulation was achieved when azobenzene unit was
located between the 10th and 11th nucleotides of the non template strand. The T7 promoter
has two functional regions known as loop binding region and the unwinding region.
Later, it was found that the introduction of two azobenzene residues into the nontemplate
strand of the T7 promoter whereas one at position-9 (in the loop binding region) and at
position-3 (in the unwinding region) afforded 7.6 fold increase in transcription rate after
irradiation with UV light (Fig.1-18b). 43

Figure 1-18: Photoswitching of transcription using T7 RNA polymerase.

1.4.5.1.2

Control RNase H activity by azobenzene

RNase H, is an enzyme which hydrolyzes RNA only when it is hybridized to the
complementary DNA. Komiyama and coworkers44 have investigated the control of
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RNase H activity through the photoisomerization of azobenzene. In their study, a model
of a 20-mer sense RNA strand was designed to hybridize to 20-mer native antisense DNA
strand and another 20-mer sense DNA strand containing five azobenzene residues as
extra residues. As illustrated in (Fig. 1-19), at the beginning the azobenzene containing
antisense DNA strands was hybridized with DNA sense forming a stable duplex (Tm =
60.8 C in the trans form). Upon illumination with UV light, the cis isomer was produced
and thus the duplex was destabilized (Tm = 42.6 C) and consequently the antisene DNA
strand is released due to the instability of the sense/antisense duplex and is hybridized to
the RNA strand, thusly RNA strand was subjected to digestion by RNase H. It was found
that the RNase H activity was increased by 3 fold after UV irradiation.

Figure 1-19: Photoregulation of RNase H activity.

1.4.6

New properties of azobenzene

It is well known that azobenzene derivatives are not inherently fluorescent which is
ascribed to the high efficiency of trans-cis photoisomerization. Kawashima and
coworkers45a,b reported the synthesis of an azobenzene fluorescent molecule by
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incorporating bis-pentafluorophenyl borane moiety at an ortho position of azobenzene as
shown in (Fig1-20). With varying donor/acceptor groups at para positions of azobenzene
led to azobenzenes characterized by its ability to emit green, yellow, orange and red
fluorescence. The fluorescence property of boron-based azobenzene derivatives is due to
the coordination of boron atom with the lone pair of azo nitrogen atom and thusly, the
isomerisation around the azo bond is restricted and consequently upon excitation of
boron-based azobenzene derivatives, the photoismoerization pathway is less favoured.

Figure 1-20: Fluorescent azobenzene due to B-N interaction.
Furthermore, Siewersten and coworkers46a,b were able to tune the photoswitching
wavelength of azobenzene. They have designed an azobenzene derivative with
unexpected properties characterized by an ethylene bridge which connects the two phenyl
rings at the ortho position. As shown in (Fig. 1-21), this design strains and disrupts the
trans isomer, therefore, the cis isomer become the more thermally stable. They were able
to obtain the trans-to-cis photoisomerization with green light irradiation (480-550 nm)
with efficiency close to 100% due to the effect of ethylene bridge, while cis -to-trans
photoisomerization occurs with near UV light ( 380-400 nm).

Figure 1-21: Bridged azobenzene
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1.5

Goals of this thesis

The aim of this thesis was to develop novel quenchers for labeling fluorescent
hybridization probes that may used for the detection of DNA mutations.
Since 4-(N,N-dimethylamino)azobenzene-4-carboxylic acid (DABCYL) is a common
quencher that used for labeling fluorescent probes, we aimed to introduce it into peptide
nucleic acid (PNA). The 4-(N,N-dimethylamino)azobenzene moiety may be introduced
into PNA as a nucleobase replacement and evaluation of its quenching and photoresponse
abilities can be done. The quenching efficiency of the 4-(N,N-dimethylamino)azobenzene moiety was evaluated in a PNA molecular beacon design.
Furthermore, because of azobenzene molecule is not able to participate in the hydrogen
bond network with nucleobases, we aimed to introduce a novel uracil-based quencher
that mimics the structure of the universal quencher DABCYL. The modified uracil is
designed to have 4-(N,N-dimethylamino)phenylazo moiety at C5 which does not interfere
with hydrogen bonding sites of uracil and therefore retain the base pairing ability with
adenine.
There are several advantages of the synthesis of modified uracil analogue with intrinsic
quenching ability such as it may use as a quencher in molecular beacon probes,
possibility to attach the modified uracil at any position of the designed oligomer and
therefore may lead to increase the stability of the formed duplex with the complementary
nucleic acid and finally, the presence of phenylazouracil moiety that can undergo
configurational change upon excitation with light at certain wavelength may lead to its
use in photoregulation of the formed duplex between oligomer that contains the modified
uracil and the complementary nucleic acid sequence.
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Chapter 2
2

Synthesis and Photophysical Studies of Azo-Based Quencher
for PNA-Molecular beacon

Using fluorescent probes for nucleic acid detection has attracted much attention due to its
efficiency, ease of synthesis and availability of commercial reporters that facilitate the
probe synthesis. Nucleic acid detection takes place by changing either the intensity of the
reporters fluorescent signal or the colour of its fluorescence. In this chapter, we describe
the synthesis of a peptide nucleic acid monomer carrying an azobenzene unit and
evaluation of its photoisomerization and quenching properties. In the following section a
brief overview on the origin of fluorescence and mechanism of fluorescence generation in
different types of fluorescent hybridization probes will be given.

2.1

Fluorescence

Luminescence is a spectrochemical process that involves the emission of light as a result
of irradiating a molecule at certain wavelength. This process is due to the molecule
absorbing photons and consequently being excited to higher electronic states. When
relaxing back to the ground state, it accompanied with emission of light. Light emission
usually takes place at longer wavelength due to loss of some of its energy as heat. The
difference between the maximum absorption and maximum emission is known as Stokes
shift referred to Sir. G. G. STOKES who described this phenomena.1
Luminescence is divided into two major types, fluorescence and phosphorescence
depending on the electronic states that photons are relaxing from as singlet (S) or triplet
(T) states, respectively, as shown in simplified Jablonski diagram (Fig. 2-1). There are
two important features that distinguish fluorophores: 1) fluorescence quantum yield and
2) life time. Fluorescence quantum yield (F), is the ratio of absorbed photons to emitted
photons. In other words, fluorescence efficiency is determined by the fraction of excited
molecules that can emit light when relaxing from excited state by fluorescence rather
than any of non-radiative mechanism.
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Figure 2-1: Jablonski diagram illustrated luminescence origin.

2.2

Fluorescence resonance energy transfer (FRET) theory
and fluorescent hybridization probes

Several types of fluorescent probes have been reported and they are all labelled with at
least one fluorophore. Upon excitation of that fluorophore at an appropirate wavelength,
it will be excited from the ground state to a higher excited single state. Relaxation of
fluorophore back to lowest singlet state is accompanied by the emission of light. Most
fluorescent detection protocols are based on the ability of nearby molecule, another
fluorophore or non-fluorescent molecule, to decrease the intensity of fluorescence.
Mainly, there are two mechanisms for fluorescent signal quenching, contact quenching
and fluorescence resonance energy transfer (FRET). In contact quenching mechanism,
an interaction between the donor (fluorophore) and the acceptor (fluorophore or
nonfluorescent molecule) is mediated through hydrogen bonding “called proton-coupled
electron transfer” forming non-fluorescent complex. The characteristic feature of contact
quenching mechanism is the absorption spectral change of the donor and acceptor at the
time of complex formation.
Fluorescence resonance energy transfer (FRET) mechanism, also called (Förster
resonance energy transfer),2 involves the transfer of the excitation energy to a nearby
acceptor in non-radiative fashion through energy exchange of the donor oscillating dipole
with an acceptor dipole that has similar resonance frequency.
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There are two main strategies behind the design of FRET probes for biological studies.
One is by designing the probe by using two fluorescent dyes. In this type a donor
fluorescent dye is irradiated at its excitation wavelength and by FRET, the excitation
energy is transferred to the acceptor fluorescent dye and consequently it is excited and
emits light at its characteristic emission wavelength. Alternatively, a probe can carry a
donor fluorescent dye at one terminus and nonfluorescent molecule which acts as
acceptor, called a quencher, at the other end. Quenchers are molecules capable of
quenching the fluorescent signal without emitting light. The efficiency of FRET relies on
the distance between the donor and acceptor and the extent of spectral overlapping
between absorption spectra of acceptor with the emission spectra of the donor as shown
in (Fig. 2-2). The effective distance between the donor and acceptor is in the range of 10100Å3 which is roughly equal to the distance between 3-30 nucleotides in DNA duplex.
The extent of spectral overlap is determined by Förster radius (RO) and FRET efficiency
(E) can be determined from equation (Eq. 2-1).
E =(1+R6/Ro)-1

(Eq. 2-1)

Where R is the distance between the donor and acceptor, Förster radius for a given donoracceptor pair, is conducted from equation (Eq.2-2).
Ro = 8.8 x 10-28 F k2n-4J (v)

(Eq. 2-2)

Where F is fluorescence quantum yield of the donor in the absence of the acceptor, n is
the refractive index of the medium, K2 is a parameter that depends on the relative
orientation of the donor and acceptor transition moment and J(v)is the spectral overlap
between the donor emission and the acceptor absorption.
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Figure 2-2: Resonance energy transfer Jablonski diagram and spectral overlap
donor emission spectra with acceptor absorption spectra.

2.2.1
2.2.1.1

Examples of fluorescent hybridization probes using FRET
mechanism
Adjacent probes or (Light Cycler™ hybridization probe)

In this technique, two single-stranded hybridization probes are designed in a way that
they bind to neighboring sites on the target nucleic acid. The donor is attached to one
probe at the 3`end while the other probe is labeled with acceptor at 5`end. Upon
hybridization with the target, the donor and acceptor are located at a distance allows
FRET to take place (Fig. 2-3).

Figure 2-3: Schematic representation for adjacent probes.

2.2.1.2

5`-Nuclease probes or (TaqMan® probes)

A 5`-Nuclease probe is single-stranded probe labeled with a donor at one end and an
acceptor at the other end and is amenable to 5`-nuclease digestion. This probe is
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designed as polymerase chain reaction primer in addition to the complementary
sequence for the target DNA. Upon hybridization to the target, DNA polymerase
extends the primer and consequently digestion of the probe by 5-nuclease is obtained.
As a result of the cleavage, the donor and acceptor are separated and consequently the
fluorescence signal intensity is increased as shown in (Fig. 2-4)

Figure 2-4: Schematic representation for 5`-nuclease probes.

2.2.1.3

Strand-displacement probes (or Yin-Yang probes)

In this technique, two complementary sequences are used whereas one sequence is
labeled with donor and the other is labeled with quencher (nonfluorescent molecule).
When the two probes are hybridized to each other forming a duplex, the fluorescence
signal is quenched. In the presence of the target DNA, it binds with one of the two probes
forming more stable hybrid and consequently the two labeled probes being separated
leading to increase in fluorescence intensity (Fig. 2-5).

Figure 2-5: Schematic representation for strand-displacement probes.

2.2.1.4

Molecular beacon

Molecular (MB) beacon technology,4 one of the applications that used fluorescent probes
in nucleic acid detection. A MB is a single stranded nucleic acid probe labelled with a
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fluorescent dye (donor) in one end and a dye (acceptor) at the other end. MB probe
design consists of three main domains: stem, loop and fluorophore/quencher pair. This
design forces the fluorescent dye to be in close proximity to the quencher as illustrated in
(Fig. 2-6). It was found that for PNA, a MB hairpin structure is not required to bring the
quencher in close proximity to the fluorophore,5 therefore it is called a stemless PNAMB. The probe sequence is chosen to be complementary to a specific target sequence that
is present in the nucleic acid to be detected. When the fluorescent dye is excited the
energy is transferred to the quencher through fluorescence resonance energy transfer
(FRET) and therefore no emission is observed. Upon hybridization with the
complementary single-stranded DNA target, the quencher is located farther from the
fluorescent dye and as consequence the fluorescence signal is produced. Most MB
probes are between 25 and 40 nucleotides long in which the recognition sequence (loop)
usually consists of 15-30 nucleotides and the stem is formed by 5-10 base pairs.

Figure 2-6 : Schematic representation for molecular beacon.
There are a plethora of commercially available fluorophores that are commonly used for
labeling fluorescent hybridization probes such as fluorescein derivatives: 5carboxyfluorescein (F) and 2',7'-dimethoxy-4',5'-dichloro-6-carboxyfluorescein (JOE)
and rhodamine derivatives as : N,N,N',N'-tetramethyl-6-carboxyrhodamine (TAMRA);
6-carboxy-X-rhodamine (ROX) and 6-carboxyrhodamine (R6G). For example, quenchers
that are commonly used are DDQ-1, Black hole quenchers (BHQ), Eclipse and Dabcyl
(Fig. 2-7). The choice of fluorophore quencher combinations is mainly based on the
emission range of the fluorophore that should overlap with the absorption range of the
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quencher to facilitate the transfer energy from the fluorophore to the quencher via FRET
and consequently quench the fluorescence of the fluorophore

Figure 2-7: Examples of fluorophores and quenchers have been used in fluorescent
probes.
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2.3

Peptide nucleic acid (PNA)

Since many human diseases are related to genetic perturbations, detection of mutations
has become an essential mission for scientists to accomplish. There are many causes
contributing to the differences in sequences such as single nucleotide polymorphisms
(SNP) or other sequence alterations such as point mutations, insertion and deletions.
SNPs are considered the most common type of genetic variation among people, and their
detection has attracted much attention.
Several techniques have been developed to detect SNPs based on nucleic acid probes
tagged with a fluorescent moiety as a reporter. Currently, the utility of the fluorescentbased probes in SNP detection is the most common strategy due to their safety.6
A remarkable example of probes that have been used is peptide nucleic acids (PNAs).
PNA, a DNA analog, was invented 20 years ago by Nielsen.7 It consists of a pseudo
polypeptide backbone that is comprised of repeating N-(2-aminoethyl)glycine units and
nucleobases are attached to the backbone via a methylene-carbonyl linker as illustrated in
(Fig. 2-8). Unlike natural nucleic acids, PNA does not contain phosphate groups and
therefore it possess a neutral character which provide stronger binding between PNA and
its complementary nucleic acid than that between DNA: DNA and DNA: RNA at low to
medium ionic strength.
The PNAs are depicted like peptide, from the N-terminus to the C- terminus, when the Nterminus of the PNA faces the 5'end of the DNA or RNA the complex is termed parallel.

Formation of duplexes can be obtained in both parallel and anti-parallel orientations but
the anti-parallel is strongly preferred. In addition, due to PNA’s artificial character they
show the ability to resist nuclease or protease degradation and consequently possess
extended lifetime both in vivo and in vitro.8
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Figure 2-8: Comparison between DNA and PNA structures.

2.3.1

PNA binding modes with nucleic acids (NAs)

PNA forms stable duplexes with single stranded-nucleic acids similar to DNA:DNA and
DNA: RNA obeying Watson-Crick base pairing rules. PNA may bind to the double
stranded-DNA through different types of binding modes9 as illustrated in (Fig. 2-9). PNA
binds with double stranded-DNA forming classical triplexes via Hoogsteen base pairing
and this type of binding requires a high cytosine content of the PNA10a,b (Fig. 2-9. A).
Homopyrimidine PNAs bind to the complementary DNA forming (PNA)2:DNA via
triplex invasion10a,b through opening the DNA double helix and one PNA strand binds to
DNA obeying Watson-Crick base pairing rules and the other PNA binds through
Hoogsteen base paring (Fig. 2-9B).
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Figure 2-9: Binding modes of PNA with double-stranded DNA.
Thymine is able to engage with adenine by Hoogsteen pairing, while cytosine requires
protonation which occurs below physiological pH to form stable Hoogsteen base pair
with guanine. Such pH dependence limits this binding and this limitation can be avoided
by replacing cytosine with pseudoisocytosines(IC) J-base12  or N7-guanine.13 PNA
with high purine content can bind with double-stranded DNA forming duplex invasion
via opening the DNA duplex helix followed by invasion of PNA (Fig. 2-9C). Finally, it
was found that PNA has the ability to bind to DNA duplex via double duplex invasion by
using modified nucleobases in the PNA strands pseudo complementary PNAs In this
type of binding, the DNA target should contain at least 50% of AT and all A/T base pairs
in PNA strand are replaced with 2,6-diaminopyrimidine/2-thiouracil base pair. The
presence of 2,6-diaminopyrimidine/2-thiouracil base pairs in PNA prevents binding of
the two PNA stands to each other due to the steric hindrance. Thusly, they bind only to
the target DNA (Fig. 2-11). PNA has shown a high binding affinity and specificity for
nucleic acids, therefore, it is considered a very interesting and potentially useful tool in
molecular biology, and may have both diagnostic and therapeutic applications.14a-c

40

Figure 2-10: Triplex invasion of double helix DNA by homopyrimidine PNA
oligomers. a) Protonated cytosine for Hoogsteen base pairing, replacing all cytosines
with b) pseudoisocytosines (J) or c) N7-guanines in the Hoogsteen strand to avoid
low pH required for N3 protonation.
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Figure 2-11: Double duplex invasion of DNA by pseudo complementary PNAs.

2.3.2 PNA modifications
Despite the attractive and interesting properties of PNA, a number of drawbacks have
been observed such as poor solubility,15 tendencies to self aggregation and poor cell
permeability.16 These limitations motivated researchers to modify the aminoethylglycine (aeg) PNA structure. A large number of PNA analogues have been synthesized
through different types of modification on the backbone and/or nucleobases. A numerous
chemical modifications on the aminoethylglycine backbone have been obtained,17 only
few have shown a practical interest such as the lysine derived backbone (Fig. 2-12).
Introduction of few lysine based monomer provides the PNA with cationic charges and
thus increase the aqueous solubility of the PNA. In addition, different chemical
modifications on nucleobase have been carried out to introduce a new functional group to
the PNA and thus new properties as luminescence, potential-helix stabilization.18a-c
Furthermore, some of non natural nucleobases have been incorporated in PNA oligomers,
as pseudoisocytosines (IC) as mentioned before it mimics the N3-protonated cytosine
(Fig. 2-13).
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Figure 2-12: Selected examples of modified PNA backbone.

Figure 2-13: Selected examples of modified PNA nucleobases.

2.3.3 Synthesis of PNA oligomers
The synthesis of PNA oligomers relies on traditional solid phase peptide synthesis
protocols (SPPS). Solid phase methodology has many advantages over the conventional
synthesis as: 1) utility of excess reagents drives reactions to completion and resulting in
increasing the reaction yield, 2) removal of reagents simply carried out by washing, 3)
due to the product is synthesized on the resin, the handling loss of the product was
minimized, 4) can be automated. On the basis of these remarkable advantages of solid
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phase, the synthesis of polypeptides on support through a repetitive synthesis cycles was
possible.
The synthesis of first PNA was reported by using Boc strategy that was heavily used in
peptide synthesis. This protocol relies on using tert-butyloxycarbonyl (tBoc) group to
protect the free amino group of PNA monomer backbone and benzyloxycarbonyl (Z)
group to protect the exocyclic amino group of A, C and G nucleobases. The differential
acid liability between tBoc and (Z) group facilitates the PNA synthesis whereas tBoc
group is removed by trifluoroacetic acid (TFA) and Z groups are removed using
trifluoromethane sulphonic acid (TFMSA). Cleavage of PNA oligomer from the solid
support usually carried out with hydrogen fluoride (HF). In Boc protocol, usually acid
labile resins as PAM (name is derived from the linker 4-(oxymethyl)phenylacetamidomethyl) which produces carboxylic C-terminal or MBHA (methylbenzhydrylamine) that produces amide C-terminal.
Some drawbacks were observed in this protocol such as during the deprotection of tBoc
with TFA neither remove of side-chain protective groups nor a cleavage of the peptide
from the resin was observed and therefore reducing the yield of the desired oligomer.
Another disadvantage of tBoc protocol is the need for hazardous chemicals such as HF
and the harsh condition for removal of Z group, that highlighted the need for new
methodology to avoid such limitations. To avoid the repetitive acid treatment of the
growing peptide in tBoc protocol, a milder method for the synthesis of the peptide with
the solid phase technique was developed. This method based on introduction of base
labile N-protecting group. Atherton and Shepard18 developed a convenient solid phase
protocol for peptide synthesis based on using fluorenylmethoxycarbonyl group (Fmoc)
for N-protection.
In Fmoc methodology, the free amino group of PNA monomer backbone is protected
with Fmoc group and benzhydryloxycarbonyl (Bhoc) group is used to protect the
nucleobase exocyclic amino group. Deprotection of Fmoc group carried out under mild
conditions using 20% piperidine in DMF forming 9-(1-piperidinylmethyl)fluorene and
piperdine carbamate salt by-products which are easily detectable spectophotometrically
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at 300-320 nm20 or via measuring the conductivity respectively, which enables the
automated monitoring of each deprotection step. At the end of the automated synthesis,
the quality of the synthesis can be assessed by inspection of the chromatogram of all
Fmoc groups removed during the synthesis cycles. Deprotection of Bhoc group is carried
out at the end of the synthesis cycle by TFA at the same time with the cleavage of the
peptide from the resin. Fmoc-based solid phase peptide synthesis protocol has been
greatly enhanced by the introduction of a variety of solid supports, linkages, and side
chain protecting groups. The cleavage of the peptide from the resin depends on the type
of support and linker that have been chosen. Mainly, acid sensitive supports are used for
Fmoc-mediated protocols as Wang resin also called HMP (4-(hydroxymethyl)phenoxymethyl)polystyrene-1% divinylbenzene resin (produces carboxylic C-terminal)
or Rink amide (produces amide C-terminal). The release of the peptide from the support
usually carried out using TFA and purification of the synthesized PNA oligomer usually
takes place via RP-HPLC and analyzed by mass spectrometry. There are two main side
reactions that may occurr during PNA synthesis as shown in (Fig. 2-14) firstly, acyl
migration of the nucleobase acetyl moiety to the N-terminal leaving the secondary amine
amenable to subsequent coupling giving a PNA with undesired sequence. Secondly,
intramolecular attack of the primary amine at the N-terminal on the carbonyl group of the
amide resulting in the lose of the N-terminal as ketopiperazine derivative. Cleavage of
peptide from resin by TFA and side-chain deprotection can lead to side reactions due to
reaction of the generated carbocations with the peptides. To overcome this problem,
scavenger is used to avoid alkylation of the peptide. The choice of scavenger is
depending on the type of side chain protective groups present. The strategy of solid phase
synthesis for peptide nucleic acid oligomer using Fmoc or Boc is illustrated in (Fig. 215).

Figure 2-14: Side reactions in PNA synthesis
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Figure 2-15: General strategy for solid phase peptide nucleic acid synthesis.
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Currently, there are two types of commercially available PNA monomers for peptide
nucleic acid synthesis. The structures of the protected PNA monomers are illustrated in
(Fig. 2-16 and 2-17).

Figure 2-16: Structures of commercially available tBoc/Z PNA monomers.

Figure 2-17: Structures of commercially available Fmoc/Bhoc monomers.
Several protecting group combinations have been investigated for the synthesis of PNAoligonucleotide conjugates as Fmoc/Acyl,21Mmt/Acyl22a,b while Fmoc/Mmt23 and Fmoc/Z
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Protecting group strategies were used in the synthesis of PNA-peptide conjugates (Fig. 218). The utility of these protecting groups is limited due to they do not allow orthogonal
synthesis with commercially available amino acid monomers. Bradley24 introduced
1-(4,4-dimethyl-2,6-dioxacyclohexyl)ethylidene (Dde) group for protecting the terminal
amino group of the backbone and monomethoxytrityl group (Mmt) for the exocyclic
amino group of the nucleobases. The Dde group is usually cleaved by hydrazine in DMF
which also deprotects the Fmoc group. A milder condition for Dde protection was
developed by Bradley using a mixture of hydroxylamine hydrochloride and imidazole
under slightly acidic conditions which would be fully orthogonal to the Fmoc group.24
o-Nitroveratryloxycarbonyl group (NVOC)/Acyl25 strategy in which NVOC group
protects the amino group of the backbone was introduced by Liu and it is easily
photolytically cleaved with irradiation at wavelength > 300nm. Some examples of
different protecting groups combinations is shown in (Fig. 2-18).

Figure 2-18: Examples of various protecting groups in PNA synthesis, protection of
exocyclic amino group in A, G and C (only cytosine is shown for
illustration).
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2.4

PNA applications

On the basis of the remarkable high binding and high specificity properties of PNA with
nucleic acids, PNAs have been employed in various biological applications as diagnostic
or detection tools in addition to its utility for controlling gene expression.

2.4.1.1

PNA as therapeutic drug

As described in section 1-1, There are basically two strategies for therapeutic drug
namely antigene and antisense. Relying on the ability of PNAs to bind with doublestranded DNA via strand invasion, PNAs have been shown to be a good candidate as
antigene or antisense agents.27 PNAs as antigene tools have been demonstrated its ability
to arrest transcription processes through formation of triplex complex with DNA via
strand invasion that confer a structural hindrance and consequently block the activity of
RNA polymerase.28 In vivo, plasmid DNA replication has been blocked by PNA.29 In
vitro, several studies have been demonstrated the ability of PNAs to inhibit DNA
replication via triplex structure by strand-invaded complexes.30
PNAs as antisense drug, relies on the recognition and binding to the complementary
sequence of m-RNA through the formation of double helix complex and thus inhibit
translation of the target gene to protein. Several reports have been introduced to illustrate
the ability of PNAs as antisense. PNA was able to block liver-specific microRNA (miR122) activity in human and rat liver cells.31a,b However, utility of PNAs as tools for
regulating gene expression was hampered by the slow cellular uptake of PNA by the
living cells due to its uncharged character. Numerous strategies have been explored to
improve the efficiency of PNA cellular uptake such as conjugation of PNA with DNA
oligomers,32 ligands as antibodies, steroids,33a,b or peptides such as cell penetrating
peptides as penetratine.34 Incorporation of positively charged residues as lysine or
arginine into PNA sequence enhanced the PNA delivery. Dragulescu and coworkers
showed that replacing the glycine side chains in PNA backbone with D-arginines forming
guanidine-based PNA (GPNA) as shown in (Fig. 2-19) improves the PNA cellular
uptake35 and inhibit protein translation.36
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Figure 2-19: Comparison between the structure of GPNA and aeg-PNA.

2.4.1.2

PNA for diagnostics and detection

The excellent hybridization properties of PNAs with nucleic acids have allowed the use
of PNA in a variety of genetic diagnostic techniques. For example, PNA-fluorescence in
situ hybridization (FISH) technique. In this technique, a fluorescently labelled PNA is
used to visualize the complementary nucleic acid target inside the cell. PNA-FISH have
been used for quantitative telomere analysis,37a,b chromosome painting, bacterial and viral
diagnostics.38a,b In 2006, advanDx’ PNA FISH probes product for in vitro diagnosis of
blood was a proved by Food and Drug Administration (FDA) of United States.
Another powerful application of PNA is PNA directed PCR clamping. In this strategy,
PNA probes are employed in detection of single base pair mutations or single-nucleotide
polymorphism (SNPs) by polymerase chain reaction technique (PCR). PNA probe was
designed to bind to one of the PCR primer sites forming PNA:DNA complex which is
effectively blocked this sites and hence inhibit amplification of the PCR product. 39a,b
Furthermore, PNA used in molecular beacon design,40 a description of molecular beacon
design is introduced in details in (section 2-2.1.4).

2.5

Results and discussion

Relying on the aforementioned remarkable properties of both azobenzene (as photoswitch
and quenching tool) and PNA as diagnostic tools, we have decided to pursue the
synthesis of PNA-MB bearing azobenzene moiety and assess the quenching ability of
appended azobenzene moiety against different types of fluorophores that used in
fluorescence studies.
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4-(N,N-Dimethylamino)azobenzene has been chosen as azobenzene analog for many
reasons, azobenzene moiety allows the photoisomerization study for the synthesized PNA
monomer. The prescence of dimethylamino group which is susceptible to protonation
facilitates the study of pH effect. Finally, the structure of 4-(N,N-dimethylamino)azobenezene PNA monomer mimics the structure of universal quencher.
4-(N,N-dimethylamino)- azobenzene-4`-carboxylic acid (DABCYL) and thus may have
potential quenching effect.

2.5.1 Synthesis of the backbone
The synthesis of PNA monomers relies on the assembly of the protected 2-aminoethyl
glycine backbone and protected nucleobase substituted acetic acid structural units. 41 We
aim to synthesize the PNA oligomer using Fmoc protocol for solid phase peptide
synthesis and therefore synthesis of Fmoc protected PNA monomer is required.
The synthesis of 4-(N,N-dimethylamino)azobenzene PNA monomer was carried out in
two steps, synthesis of the tert-butyl-1-(2-(Fmoc)aminoethyl)glycinate backbone and
nucleobase acetic acid derivative. The Fmoc(aeg)tert butyl ester backbone was obtained
according to the synthetic route outlined in (Scheme 2-1) following the method reported
in the literature.42 tert-Butyl-1-(2-aminoethyl)glycinate II-1 was obtained by reaction of
ethylenediamine with tert-butyl bromoacetate in dichloromethane followed by protecting
the free amino group by N-(9-fluorenylmethoxycarbonyloxy) succinimide (Fmoc-OSu) to
afford the backbone as oil. Fmoc backbone II-2 was isolated as the hydrochloride salt by
acidifying the solution with HCl/ether solution.

Scheme 2-1: Synthesis of 2-Fmoc(aeg)-t-butyl ester backbone.
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2.5.2 Synthesis of the dimethylaminoazobenzene PNA monomer
The synthesis of PNA monomer carrying 4-(N,N-dimethylamino)azobenzene as shown in
(Scheme 2-2) was obtained via series of chemical transformations started with
diazotization

of

p-aminophenylacetic

acid

followed

by

coupling

with

N,N-

dimethylaniline to give 4-(N,N-dimethylamino)azobenzene-4-acetic acid II-3 in 80%
yield.

II-3

was

coupled

with

tert-butyl-N-[2-(Fmoc)aminoethyl]glycinate

by

dicyclohexylcarbodiimide (DCC) mediated coupling to give the tert-butyl ester derivative
II-4 in 73% yield . Finally, the tert-butyl group was removed by trifluoroacetic acid in
dichloromethane to afford the azobenzene PNA monomer II-5 in 91% yield.

Scheme 2-2: Synthesis of azo-based PNA monomer.

2.5.3 Effect of acid on dimethylaminoazobenzene PNA monomer
The presence of the dimethylamino group imparts a susceptibility to protonation which
facilitates the study of pH effects on the azo-based PNA monomer II-5 (halochromism).
The behavior of 4-(N,N-dimethylamino)azobenzene moiety under acidic conditions have
been investigated. An ethanol solution of II-5 was titrated with trifluoroacetic acid (0.005
M). Upon addition of trifluoroacetic acid, a decrease in the - absorption band for non-
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protonated form at 409 nm with an increase in - absorption band for protonated form
at 524 nm was observed with isosbestic point at 465 nm as shown in (Fig. 2-20). This
spectral change is explained with the aid of (Scheme 2-3). Although there are two basic
sites in azo-PNA monomer II-5, dimethylamino and azo groups,43 protonation in ethanol
favors the lower energy, resonance-stabilized azonium ion over the ammonium ion.
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Figure 2-20: Changes in the UV-vis absorption spectrum of II-5 in EtOH at 1.66X105

M during titration with trifluoroacetic acid, from 0.3 to 2.4 equivalents.

Scheme 2-3: Ammonium/azonium protonated ions of dimethylaminoazobenzene.

2.5.4

Photoisomerization studies

Photoisomerization of azobenzene is well established, azobenzene can readily undergo
conformational change about the azo bond between the trans and cis geometrical isomers
by light. The trans-isomer can be photoisomerized to the cis-isomer upon illumination
with UV light (300 < < 400nm), while cis isomers can be converted back to the trans
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isomer again either by irradiation with visible light ( > 400nm) or thermally. The
isomerization is completely reversible.
By using UV/Vis spectroscopy for monitoring the photoisomerization of azo-based PNA
monomer II-5 in dichloromethane, It was observed that with irradiation of II-5 with UVlight at 366 nm from hand held source, a decrease in the absorption band centered at 411
nm with appearance of unexpected large peak at 525 nm similar to the peak observed in
effect of acids of II-5 study (Fig. 2-20), this may attributed to generation of acid under
irradiation condition. To circumvent the effect of acid, the irradiation was necessarily
obtained in the presence of base. Under basic condition, upon illumination of II-5 UVlight at 366 nm for a period of time, a decrease in the intensity of -* band at 411 nm
was observed. Recovery of trans-isomer was obtained by heat and it was confirmed by
growth of the absorption band at 411 nm. (Fig. 2-21)
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Figure 2-21: UV-Vis spectral change of II-5 in dichloromethane. a) under
irradiation at 366 nm, monitored at the time points shown. b) Recovery of the trans
absorption band at 411nm by heat at rate 1C/min.

2.5.5 Quenching ability of dimethylaminoazobenzene PNA monomer
A

preliminary,

qualitative

study

to

assess

the

ability

of

the

4-(N,N-

dimethylamino)azobenzene PNA monomer to quench the emission of fluorescein, pyrene
and sulforhodamine luminophores was made. PNA monomer II-5 is an analog of the
well-established FRET quencher DABCYL. PNA monomer II-5 has a strong, broad
absorption the spanning the near UV and visible region centered at approximately 410
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nm in ethanol. This absorbance overlaps with the emission of several commonly used
fluorophores, when in close proximity, may quench the fluorescence via (FRET). The
ability of the II-5, to effect intermolecular quenching of representative appropriate
fluorophores was observed for fluorescein (excitation = 488 nm; emission = 525 nm) and
pyrene (excitation = 330 nm; emission = 377, 395 and 418 nm) as demonstrated in (Fig. 222).
The authenticity of the quenching effect observed for fluorophores that matched their
emission to the absorption band of II-5 was confirmed by using a dye that is not a
suitable FRET partner: sulforhodamine. The sulforhodamine dye is a longer wavelength
emitting dye (excitation = 550 nm; emission = 595 nm) and is not suitable for use with
DABCYL. The results shown in (Fig. 2-22) also indicate that the PNA monomer II-5
behaves in an analogous fashion as free DABCYL, and does not cause any significant
fluorescence quenching) The small (overall 7%) decrease in fluorescence intensity is
likely due to dilution or screening effects. These results provide a direct evidence of the
quenching ability of the synthesized 4-(N,N-dimethylamino)azo-PNA monomer.
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A)

B)

Figure 2-22: The effect of increasing amounts of II-5 on the emission spectra of A)
fluorescein and B) pyrene, 5 mol of each. Spectra were recorded in absolute EtOH
and room temperature, excitation (fluorescein) = 488 nm and, excitation (pyrene) = 330
nm.

Figure 2-23: The effect of increasing amounts of II-5 on the fluorescence emission
spectra of sulforhodamine 640 dye, excitation= 550 nm. Inset, expansion of the peak
centered at ~590 nm.
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Figure 2-24: Structures of the fluorophores used in the study.

2.5.6 Design and synthesis of dual-labeled PNA molecular beacon
In order to assess the quenching ability of the azo-based PNA monomer in biological
environment, 4-(N,N-dimethylamino)azobenzene unit was incorporated into short 8-mer
PNA sequence FCTTTTTCAz (II-6), Az is azo-based monomer at C-terminus and F is
the fluorescein moiety at N-terminus of a molecular beacon design using standard solidphase PNA synthetic protocols using Fmoc protected monomers on a lysinefunctionalized Rink amid resin (Nova Syn® TGR). Once the PNA oligomer synthesis
with uncapped N- terminus was achieved, the resin was divided into two portions, first
portion was treated with TFA to release the oligomer (II-6) which will be used later for
hybridization studies to assess the effect of the presence of azobenzene on the stability of
the triplex formation with the complementary DNA sequence. Fluorescein isocyanate

57

(FITC) was coupled manually to the uncapped N-terminus oligomer-bound resin (second
portion). The completion of FITC coupling was confirmed by Kaiser test44 and the PNAMB (II-7) was purified by reversed phase-HPLC and characterized by MALDI-TOF
mass spectrometry as shown in (Fig. 2-25 and 2-26).
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Figure 2-25: Mass spectrum of azo-based PNA oligomer II-6, calculated 2345.0335,
found 2345.0468 [MH+]
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Figure 2-26: Mass spectrum of PNA-MB II-7, Calculated 2735.0772, found
2735.1440 [MH+]
On the basis of the quenching results that 4-(N,N-dimethylamino)azobenzene PNA
monomer has proven. Molecular beacon design allows the presence of the azobenzene
moiety in close proximity to the fluorophore and as a result the fluorescence signal of the
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fluorescein should be turned off or decreased due to FRET. As illustrated in figure (Fig.
2-27), upon duplex formation between the PNA-MB (II-7) and the cDNA
5`-TCGAAAAAGCT-`3 at 2 M scale the fluorophore is located in a distance from the
4-(N,N-dimethylamino)azobenzene unit and as consequence the fluorescence intensity
was increased by over 100 fold.

Figure 2-27: Fluorescence emission spectra (ecitation= 488 nm) of 4-(N,Ndimethylamino)azobenzene based PNA-MB at 2 M scale under ionic
condition 100 mM NaCl, 10 mM Na2HPO4, 0.1 mM EDTA, pH 7.0, PNAMB-cDNA (solid line)and PNA-MB(dotted line).

2.5.6.1

Hybridization properties of dimethylaminoazobenzene-PNA
sequence

To evaluate the influence of 4-(N,N-dimethylamino)azobenzene moiety in the stability of
the duplex formed between the azo-based PNA oligomer (II-6) and the complementary
counterpart sequence “5`-TCGAAAAAGCT-3`”. The hybridization properties were
studied by temperature dependent UV absorbance in 2:1 ratio at (6 M PNA: 3 M
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cDNA) was evaluated near physiological ionic conditions (100 mM NaCl, 10 mM
Na2HPO4, 0.1 mM EDTA at pH 7.0). It was found that incorporation of 4-N,N-dimethylaminoazobenzene moiety into PNA oligomer resulted in an increase of melting
temperature ΔTm (+11 °C, with DNA) comparing to a control PNA oligomer. This
increase in stability is may ascribed to the presence of hydrophobic azobenzene moiety at
the end of the triplex structure that expected to stack well and therefore preventing end
fraying.

cDNA: 5`-TCGAAAAAGCT-3`
Tm C

Δ Tm

II-6, CTTTTTCX
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+11

Control PNA, CTTTTTC

41

---------------

Table 2-1: Melting Temperature

Figure 2-28: Schematic representation for formation of triplex PNA2:DNA
stabilized by azobenzene units.

2.6

Conclusion

We have described the synthesis of an Fmoc-PNA monomer possessing an integral
4-(N,N-dimethylamino)azobenzene moiety as a nucleobase surrogate. This PNA
monomer showed the ability to undergo a light-driven configurational change which
might be beneficial for photoregulation of duplex stability between the PNA and
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complementary nucleic acid. The azo-based PNA monomer also showed the ability to
quench the fluorescence of fluorescein and pyrene and would be compatible with the
same panel of dyes for which DABCYL is an effective quencher. The azo-based PNA
monomer was successfully incorporated into oligomer using standard Fmoc-based
oligomerization in a molecular beacon design with fluorescein as the optical label. As a
result of hybridization of the azo-based PNA-MB to its complementary DNA, an increase
of the fluorescence signal by 100 fold was observed.

2.7

Experimental

tert-Butyl-N-[2(-((9H-fluoren-9-yl)methoxy)carbonyl]amino)ethyl]amino]acetate
HCl salt II-2
To a stirred solution of ethylenediamine (20 mL, 0.3 mol) in
CH2Cl2 (150 mL) at 0 C, tert-butyl bromoacetate (4 mL,
0.03 mol) in CH2Cl2 (20 mL) was added with slowly
addition over 5 h. The mixture was allowed to warm to r.t. and was stirred for 16 h. The
mixture was washed with water (3 x 200 mL) and the combined organic solvent was
collected, dried over Na2SO4 and filtered. A sample (1 mL) of the organic was evaporated
and was dried to give product II-2 as oil: 1H NMR (CDC13) : 3.29 (s, 2 H), 2.77 (t, J =
7.0 Hz, 2H), 2.65 (t, J = 7.0 Hz, 2H), 1.51 (s, 3H), 1.45 (s, 9H). To the filtered solution
(4.35 g, 0.025 mol) DIEA (10.6 mL, 0.075 mol) was added followed by dropwise
addition of FmocOSu (8.43 g, 0.025 mol) in CH2Cl2 (25 mL) over 5 hr and the mixture
was stirred for 12 h. The mixture was washed with water (3 x 200 mL) and was dried
over Na2SO4 and filtered then was concentrated under reduced pressure to (50 mL). A
solution of saturated HCl/diethylether (8 mL) was added to the reaction mixture till the
solution turned turbid, cooled at 0 C for 3 h and the resulted white solid was collected,
dried to give the hydrochloride salt of the backbone (6.5 g, 60 %). 1H NMR (DMSO-d6)
for II-2 : 9.27 (s, 2 H), 7.88 (d, J = 7.4 Hz, 2H), 7.68 (d, J = 7.4 Hz, 2H), 7.56 (t, J = 5.8
Hz, 1H), 7.41 (t, J = 7.3 Hz, 2H), 7.32 (t, J = 7.3 Hz, 2H), 4.33 (d, J = 6.8 Hz, 2H), 4.22
(t, J = 6.6 Hz, 1H), 3.86 (s, 2H), 3.32 (m, 2H), 2.98 (t, J = 6 Hz, 2H), 1.44 (s, 9 H).
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4-[4-(N,N-Dimethylamino)phenyl]diazenyl]phenylacetic acid II-3.
To an ice-cooled stirred solution of 4-aminophenylacetic acid (1.0 g, 6.62
mmol) in 1 M HCl (30 mL), a cold solution of sodium nitrite (0.685 g,
9.93 mmol) in H2O (3 mL) was added dropwise. The mixture was stirred
for 30 min and the resultant solution of diazonium salt was transferred to
dropping funnel then was added to a solution of N,N-dimethylaniline
(1 mL, 7.94 mmol) in a mixture of glacial acetic acid and water (30 mL, 2:1, v/v). The
mixture was stirred for 3 h. A brown solid precipitated after the pH was adjusted to 8 by
use of an aqueous solution of 2 M sodium acetate. The solid was collected by filtration
and was washed sequentially with cold water and ether and then dried to give product II3 in pure form (1.49 g, 80%), 1HNMR (400 MHz,CDCl3)  : 7.78 (d, J = 8.9Hz, 2H),
7.72 (d, J = 8.2Hz, 2H), 7.40 (d, J = 8.2 Hz, 2H), 6.76 (d, J = 8.6 Hz, 2H), 3.7 (s, 2H),
3.07 (s, 6H);

13

C NMR (100 MHz,CDCl3)  : 177.1, 152.3, 143.6, 134.4, 129.8, 124.9,

122.4, 111.5, 40.8, 40.3. HRMS (EI): calcd. For C16H17N3O2 [M+] 283.1321, found
283.1323.
tert-Butyl-2-[N -(2-((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl]-2-[4-((4-(N,Ndimethylamino)phenyl)diazenyl)phenyl)acetamido] acetate II-4.
To a solution of II-3 (0.5 g, 1.76 mmol) in dry DMF (7 mL), DCC
(0.366 g, 1.76 mmol) and HOBt (0.238 g, 1.76 mmol) was added.
The reaction mixture was degased for 15 min and then was stirred
for 1 h followed by the dropwise addition of a solution of the
Fmoc-backbone ester, tert-butyl 2-(2-(((9H-fluoren-9-yl)methoxy)
carbonylamino)ethylamino)acetate, (0.635 g, 1.6 mmol) in (5 mL)
of dichloromethane. The mixture was stirred at r.t. for 36 h. The formed DCU was
filtered; the filtrate was poured into ice-water with stirring which produced a brown
precipitate. The solids were collected by filtration and then subjected to column
chromatography using hexane/CH2Cl2 (70:30 v/v) as the eluent to afford II-3 (0.852 g,
73%). Compound II-3 exists in solution as a pair of slowly exchanging rotamers; signals
attributed to major (ma.) and minor (mi.) rotomers are designated: 1HNMR ( 400 MHz,
CDCl3)  : 7.82 (d, J = 8.2 Hz, 2H), 7.79-7.74 (m, 4H), 7.58 (d, J = 7.4 Hz, 2H), 7.38-
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7.27 (m, 6H), 6.74 (d, J = 8.2 Hz, 2H), 4.38 (d, J = 7.1 Hz, 2H ), 4.22 (m, 1H), 3.95 (s,
mi., 0.6H), 3.91 (s, ma., 1.4H), 3.75 (s, ma., 1.3H), 3.67 ( s, mi., 0.7H), 3.58-3.48 (m,
2H), 3.39-3.31 (m, 2H), 3.07 (s, 6H), 1.48 (s, 9H); 13C NMR (100 MHz,CDCl3)  : 156.5,
152.4, 143.7, 141.2, 129.5, 127.6, 127.1, 125.0, 119.9, 112.6, 83.1, 82.3, 49.9, 47.1, 40.8,
28.0. HRMS (ESI): calcd. For C19H44N5O5 [MH+] 662.3342, found 662.3328.

2-(N-(2-(((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl)-2-(4-((4’-N,N-dimethyl
amino)-phenyl)diazenyl)phenyl)acetamido)acetic acid II-5.
To an ice-cooled suspension of compound II-4 (0.5 g, 0.75 mmol)
in dichloromethane (2 mL), TFA (2 mL) was slowly added and the
reaction mixture was stirred for 1 hr in ice bath and for 3 h at r.t.
The mixture was evaporated in vacuo to dryness and the remaining
residue was coevaporated with dichloromethane (3 x 10 mL), was
dissolved in dichloromethane (2 mL) and precipitated with the
addition of diethyl ether (30 mL). The mixture was cooled to 0 C for 12 h, filtered,
washed with cold ether and dried to give the title compound as red solid (0.416 g, 91 %).
1

H NMR (400 MHz, DMSO)  : 8.11 (s, 1H), 7.89 (d, J = 7.4 Hz, 2H), 7.77 (d, J = 8.6

Hz, 2H), 7.69-7.66 (m, 4H), 7.40-7.30 (m, 6H), 6.83 (d, J = 8.6 Hz, 2H), 4.31 (m, 1H),
4.20 (d, J = 6.6 Hz, 2H), 3.85 (s, ma., 0.5H), 375 (s, mi., 1.5H), 3.63 (s, 2H), 3.40 (m,
2H), 3.19 (m, 2H), 3.05 (s, 6H);

13

C NMR( 100 MHz, DCM-d2)  : 161.1, 157.4, 144.4,

141.7, 136.5, 131.1, 128.2, 127.6, 125.6, 120.4, 119.9, 115.8, 76.3, 67.5, 47.6, 42.1, 40.
HRMS (ESI): calcd. For C35H36N5O5 [MH]+ 606.2716, found 606.2739
PNA Oligomer and PNA-MB synthesis
PNA 8-mer was synthesized on a 5 mol scale using the standard FastMoc module on an
Applied Biosystems 433A synthesizer using Nova SynTGR (Rink amide) resin. After the
PNA synthesis was completed with uncapped N-terminus, the resin (40 mg, ~ 2 mol)
was transferred to a reaction vessel and was washed and drained with dry CH2Cl2 and
DMF several times, DMF (1mL), FITC (6 equiv.) and DIEA (10 equiv.) were added and
the reaction mixture was shaken in the dark for 6 h. The resin was washed with CH2Cl2
and DMF, completion of FITC coupling was confirmed by Kaiser test.
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Cleavage of the PNA-MB from the resin
The PNA was cleaved from the resin with of TFA (1mL) for 90 min and the reaction
mixture was filtered, the filtrate was evaporated with nitrogen stream and was treated
with cold anhydrous diethyl ether (1 mL) to precipitate the crude PNA. The crude PNAs
were dissolved in 0.05% TFA-H2O (300 L), filtered, and purified by RP-HPLC using a
250 mm x 4.6 mm, C18-bonded phase, 100 pore, 5 μm particle size column. Column was
eluted at a flow rate of 1mL/ min with the solvent system: A) TFA (0.05%, v/v) in H2o
and B) TFA (0.05%, v/v) in CH3CN with a binary gradient elution 0-5 min, 100% A; 520 min, 100% to 60% A; 20-30 min, 60% to 40% A; 30-40 min, 40% to 0% and were
characterized by MALDI-TOF mass spectrometry, for II-6 found 2345.0468 [MH+] ,
(2345.0335. calcd. for C101H136N38O29) and for II-7 found 2735.1440 [MH+] ,
(2735.0772. calcd. for C122 H148 N39O34S.
PNA stock solutions were prepared in deionized water and stored at -4°C. Concentrations
of PNA oligomer were determined by measuring UV absorbance at 260 nm at 80 °C and
the extinction coefficients were calculated by summing the values for the individual
nucleobases, FITC (70000 M-1 cm-1), and 4-(N,N-dimethylamino)azobenzene (32600
M-1 cm-1).
Photoisomerization study
UV-Vis spectra were measured with a Varian Cary 300 Bio spectrophotometer. A
solution of II-5 (2.06 × 10-5 M) in dichloromethane with 7.08 × 10-2 M of NEt3 was
irradiated in a quartz cuvette at room temperature using a UVGL-58 hand held lamp (6
watt, 366 nm) at a distance of approximately 4 cm. At given time points, a UV-visible
spectrum was collected. The time course for spontaneous reversion was monitored at the
wavelength of maximum change (411 nm).

Fluorescence studies
Fluorescence measurements were carried out on a Photon Technologies International
Quanta Master 7/2005 spectrophotometer, excited at 488 nm and detected at 490-650nm.
First, the fluorescence intensity was measure for a sample of 2 M of azo-based PNA-
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MB under ionic conditions (100 mM NaCl, 10 mM Na2HP04, 0.1 mM EDTA at pH 7.0)
in 1 cm-qartz cuvette. The cDNA at 2 M concentration was added to the PNA-MB and
incubated for 1 hr to form duplex with the PNA-MB (II-7) and followed by measuring
the fluorescence intensity of fluorescien.
Hybridization studies:
Hybridization and UV melting experiments were carried on a Varian Cary III under the
same buffer condition used previously, melting experiments were performed at 6 μM
concentration for PNA-MB and 3 μM concentration for cDNA (2:1) ratio for triplex
formation. Sample was heated to 95 °C for 2-3 min, cooled to room temperature over 45
min. Denaturation was performed from 10 °C to 85 °C at a scan rate of 0.5 °C/min. The
Tm values are an average of three measurements and are rounded to the nearest 0.5 °C.
The error in Tm values was ± 0.5 °C. Tm values were estimated for cooperative transitions
by the first derivative method. ΔTm values are the difference between the melting
temperature Tm of azo-based PNA oligomer (II-6) and the PNA control sequence
[without 4-(N,N-dimethylamino)azobenzene monomer]
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Chapter 3
3
3.1

Synthesis and Photophysical Studies of Novel Quencher for
PNA
Introduction

To the best of our knowledge introduction of azobenzene derivatives into peptide nucleic
acid was accomplished by inclusion of azobenzene residues as a replacement for the
nucleobases. (Fig. 3.1).1a-c In this chapter, we are interested in the synthesis of a novel
azo-based PNA monomer that possess the azophenyl moiety which provides the
photoswitching property in addition to its potential quenching effect with maintaining
hydrogen bonding ability with the complementary nucleobase. To achieve this goal,
uracil nucleobase has been chosen as starting point, by simple chemical modifications to
introduce phenylazo moiety at C-5 position which is characterized by it does not interfere
with the hydrogen bonding sites of uracil.

Figure 3-1: Examples of azo-based PNA monomers.
We are interested in the synthesis of 4-(N,N-dimethylamino)phenylazouracil analog
(DMA) because it structurally mimics the universal 4-(N,N-dimethylamino)azobenzene4-benzoic acid quencher (DABCYL) that is widely used in Fluorescence Resonance
Energy Transfer (FRET) applications as shown in (Fig. 3-2), and this may leads to a new
PNA-quencher.
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Figure 3-2: Similarity in structure between DABCYL and the modified uracil

3.2

Results and discussion

The synthesis of azo-based PNA monomer is outlined in (Scheme 3-1). Starting with
diazotization of commercially available 5-aminouracil affords the corresponding
diazonium salt solution followed by coupling with N,N-dimethyl aniline following the
reported procedure2 to give 4-(N,N-dimethylamino)phenylazouracil III-1 in 80% yield.
Alkylation of compound III-1 with t-butyl bromoacetate under basic conditions at N-1 to
afford the corresponding ester III-2 which underwent removal of t-butyl group by TFA
treatment to obtain the acid derivative III-3 in 90% yield. Carbodiimide mediated
condensation of III-3 with N-[2-(Fmoc)aminoethyl]glycine-t-butyl ester gave the desired
monomer ester III-4. Finally, removal of t-butyl group was carried out by acidolysis
using TFA to give the azo-based PNA monomer III-5 in 89% yield.

Scheme 3-1: Synthesis of 4-(N,N-dimethylamino)phenylazouracil PNA monomer.
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Azobenzenes are known to have two configurational isomers which are trans and cis. The
trans isomer is the most thermally stable due to lack of steric clash that was found in cis
isomer. Similarly, 4-(N,N-dimethylamino)phenylazouracil derivatives are expected to
exist in trans form. To confirm this assumption, a crystal structure of tert-butyl-4-(N,Ndimethylamino)phenylazo-5-uracil-1-yl acetate III-2 was obtained that confirmed the
trans configuration as shown in (Fig. 3-3). Selected bond distances (Å) and angles (°),
with estimated standard deviations in parentheses is shown in Table 3-1.

Figure 3-3: The X-ray crystal structure of III-2 showing the phenylazouracil unit is
existing in trans-configuration.
Bond lengths Å]

Angles [°]

N3-N2

1.268(4)

N2-N3-C32

110.6(3)

N3-C32

1.424(4)

C33-C32-N3

122.6(3)

N2-C8

1.408(4)

N3 C32 C31

117.6(3)

N4-C11

1.454(4)

C35-N4-C11

117.5(3)

N5-C35

1.364(4)

C35-N5-C31

127.5(3)

N4-C11

1.454(4)

C33-N4-C11

120.4(3)

Table 3-1: Selected bond distances (Å) and angles (°) for III-2
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3.2.1

Photoisomerization of azo-based uracil derivative and solvent
effect on its absorption spectrum

Similarly to azobenzene, 4-(N,N-dimethylamino)phenylazouracil derivatives are expected
to undergo a transformation from the thermally stable trans isomer to the cis form by
irradiation with UV light, while the reverse transformation cis-to-trans can be achieved
either by illumination with visible light or thermally.3a,b

Figure 3-4: Photoisomerization of 4-(N,N-dimethylamino)phenylazouracil
derivatives.
4-(N,N-Dimethylamino)phenylazouracil acetic acid III-3 has been chosen as a model to
investigate its photoisomerization ability due to it showed good solubility in water and
various organic solvents. The maximum absorption band and molar extinction coefficient
of III-3 under different solvent is reported in (Table 1).

Solvent

H2O

EtOH

CH3CN

MeOH

Acetone

DCM

max/nm

465

436

439

441

437

459

(L/Mol.cm-1)

14480

32474

24855

27087

28982

-----

Table 3-2: Maximum absorption wavelength and molar extinction coefficient of
compound III-3 in various solvents.
As shown in (Table 3-2), compound III-3 showed positive solvatochromic effect, in other
words, the absorption maximum wavelength is increased with the increase of solvent
polarity. As demonstrated in (Fig. 3-5), UV-Vis absorption spectrum of III-3 in
acetonitrile exhibited a characteristic broad absorption band centered at 439 nm
corresponding to -* transition of azophenyl moiety. Upon illumination with 366 nm
light, compound III-3 underwent trans-to-cis isomerization accompanied with decrease
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in the intensity of -* band at 439 nm which is derived mainly from the azo moiety.
Recovery of trans isomer was achieved by thermal relaxation.
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Figure 3-5: Absorption spectrum of III-3 in CH3CN at 3.78 M. The arrow indicates
the direction of change in peak at 439 nm upon irradiation with 366 nm light.

3.2.2

pH-Sensitivity of azo-based uracil

Similar to the acid effect study that was carried out on the azobenzene PNA monomer
(discusses in chapter 2), on the basis of structural similarity between 4-(N,N-dimethylamino)azobenzene and 4-(N,N-dimethylamino)phenylazouracil, we have investigated the
effect of acids on compound III-3 using UV-Vis spectroscopy.

Figure 3-6: Schematic representation of azonium and ammonium ions.
As shown in (Fig. 3-6), there are two sites, dimethylamino- and azo groups, susceptible
for protonation. Interestingly, upon addition aqueous solution of 3 mM HCl to compound
III-3 in different solvents, in nonpolar solvents as benzene and toluene only azonium ion
band (usually appears at > 500nm) was observed while with the increase of solvent
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polarity both azonium and ammonium ions (usually appears at < 400)4 bands were
observed (Fig. 3-7).

Solvent

DMSO

H2O

EtOH

CH3CN

MeOH

Acetone

DCM

Toluene

Benzene

453

469

436

439

441

437

459

452

452

351

349

585/359

595

593/351

587

612

607

605

max/nm
(Neutral)
max/nm
(protonated)

Table 3-3: Effect of addition of 3 mM HCl on absorption maximum wavelength
(max) of III-3, max of ammonium ion is shown in bold.

Figure 3-7: Spectral change of III-3 at a) 10.5 M concentration in CH3COCH3
b) 8 M concentration in CH3CN upon addition of 3 mM HCl.
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As demonstrated in (Fig. 3-8), we monitored the effect of TFA on III-3
spectroscopically. Upon addition of small aliquots of TFA in acetonitrile (0.005 M) to
III-3 in acetonitrile, a noticeable decrease of the non-protonated -* absorption band
centered at 439 nm was observed, similar to the effect of HCl, with appearance of a new
absorption band at 595 nm for the protonated form with clear isosbestic point at 504 nm.
Comparing these results with that carried out in ethanol, nonprotonated form appeared at
436 nm, while after protonation with ethanolic solution of TFA, two new absorption
bands at 352 nm and 585 nm were observed. This phenomenon can be explained based
on the fact that due to the presence of two sites dimethylamino- and azo groups which are
amenable for protonation with the acid producing ammonium ion and azonium ion,
respectively.
0.5
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2.0x10-6 M
4.0x10-6 M
6.0x10-6 M
8.0x10-6 M
10x10-6 M
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Absorbance

0.4

0.3

0.2

0.1

0
220

320

420

520

620

Wavelength (nm)

0.3
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Figure 3-8: Effect of TFA on III-3 at a) 10.5 M concentration in CH3CN at range
(0-18M) (0-1.7 equivalent), b) at 6 M concentration in EtOH at range (0-14 M)
(0-2.3 equivalent), arrow directions indicates the spectral change upon addition of
TFA.
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Interestingly, azo-nucleobase derivative III-3 displayed intriguing halochromism
property. It was observed that treatment of III-3 in various solvents with halogenated
acids, as trifluoroacetic acid, gave dramatically different colours. Halogenated solvents as
chloroform or dichloromethane produced a deep blue colour. While under basic
conditions the reversible change to deep yellow/orange was observed (Fig. 3-9 and 3-10).
Surprisingly, mineral acids did not effect this colour change, nor was the colour change
observed in oxygenated solvents (H2O, alcohols, Et2O, EtOAc, and THF). The blue
colour in halogenated solvents was not quenched by shaking against water either. These
perplexing phenomena continue to be investigated which may lead to its use as a nonaqueous pH indicator.

Figure 3-9: Compound III-3 in a) various solvents: from left to right: dioxane,
dichloromethane, chloroform, diethyl ether, methanol, ethanol and H2O. b) after
addition of TFA., c) after basification.

Figure 3-10: Compound III-3 in DCM with A) Trifluoroacetic acid, B:
Dichloroacetic acid, c: fluorodichloroacetic acid, D: trichloroacetic acid, E: AcOH.
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To assess the quenching ability of the azo-based PNA monomer III-3, a preliminary
study using similar protocol that has been used in chapter 2, two fluorophores:
fluorescein and pyrene were used. As shown from the absorption spectra of III-3 in
ethanol, it has absorption range 350-525 nm with maximum wavelength 436 nm which is
expectedly overlap with emission spectra of fluorophores that used in the study. A
solution of fluorophores in ethanol was titrated with aliquots of compound III-3. As
illustrated in (Fig. 3-11 and 3-12), upon addition of small portions of III-3 to the
fluorophore, a subsequent fluorescent signal is quenched with the increase of III-3
concentrations.
3
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Figure 3-11: Fluorescence changes of 8 M fluorescein upon addition of various
amount of III-3 in EtOH at the range (0-0.1 M) with excitation wavelength 488 nm.
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Figure 3-12: Fluorescence spectra of 5 M concentration of pyrene in ethanol
recorded upon addition of varied amount of III-3 in EtOH at the range (0-1 M)
with excitation wavelength 330 nm.
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3.2.3

Design and synthesis of dual peptide for quenching study

We have designed and synthesized a FRET-peptide MB containing the azo-based PNA
monomer. FRET peptides are peptides labeled with fluorescent dye (donor) at one
terminal and a non fluorescent dye (acceptor) at the other terminal, due to presence of the
donor and acceptor in close proximity no fluorescence emission is observed due to
fluorescence energy transfer (FRET). FRET peptides are widely used mainly for
detection of proteases and protein kinases activities.5 The choice of both donor and
acceptor is very crucial to have a good FRET peptide. The donor should have high
fluorescence quantum yield and the acceptor should have the ability to quench the
emission of the donor. In other words, the emission spectrum of the donor must overlap
with the excitation spectrum of the acceptor. As illustrated in (Fig 3-13), when the
acceptor is close enough, excitation is transferred from the donor to the acceptor without
emission of photons and as a result the fluorescence of the donor is quenched. By the
effect of enzymatic degradation on a specific site of peptide sequence, the donor
separates from the acceptor and subsequently the quenching effect is lost and leading to
increase of the emission intensity of the donor.

Figure 3-13: Schematic representation on the mechanism of FRET-Peptide.
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The peptide sequence is determined based on the given protease; in this study we have
used Cathepsin D (Cat D), lysosomal aspartyl endopeptidase. Cat D is known to cleave
peptide bonds mainly between hydrophobic amino acids units.6a,b, As shown in (Fig. 314), we have designed a peptide sequence, contains core cleavage sequence (ILFFRL)
based on literature report7 showed that Cat D was effectively cleaved the peptide bond
between the two phenylalanine units. The synthesized PNA was labelled with fluorescein
as optical tag at the N-terminal.

Figure 3-14: Designed FRET Peptide having azo-based PNA monomer as quencher
and FITC as fluorophore.
The desired FRET peptide was synthesized by Fmoc mediated solid peptide phase
strategy. After the completion of the sequence synthesis, fluorescein was introduced
manually to the uncapped N terminal and completion of the fluorescein labelling was
confirmed by Kaiser test. The peptide was cleaved from the resin by TFA and was
purified by reversed phase high pressure liquid chromatography. To confirm the
formation of the synthesized peptide by mass spectrometry, unfortunately, the expected
mass for the desired dual labelled peptide cannot be observed. The mass spectrum has
shown a peak at m/z 1478.8732. It was found that this mass peak is attributed to the
peptide sequence ILFFRLA-XAK with no evidence of the presence of fluorescein
moiety or the last amino acid glycine. By reviewing the literatures, a similar case was
reported by Jullian and coworkers,8 they postulated that this type of degradation could
occurred during the cleavage of the peptide from the resin by TFA through a cyclization
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leading to the formation of a fluorescein thiohydanation with subsequent removal of the
last amino acid following a mechanism similar to Edman degradation9 (Scheme 3-2).

Scheme 3-2: Degradation mechanism of FITC labelled peptide by the effect of TFA.
As illustrated in the mechanism, formation of five-membered ring is only possible when
the last residue is -amino acid. Simply to avoid such degradation, this can be achieved
by using resin that susceptible to non-acidic cleavage of the targeted peptide or by using
longer spacer as -alanine or amino hexanoic acid.
To circumvent the degradation of the peptide, we have modified the design of the peptide
by replacing glycine residue with -alanine (Fig. 3-16) and the desired peptide sequence
was built at the peptide synthesizer followed by coupling of fluorescien manually. The
synthesis of the FRET-peptide was confirmed primarily from UV-Vis spectra as shown in
(Fig. 3-15) absorption band at 465 nm attributed to 4-(N,N-dimethylamino)
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phenylazouracil and at 485 nm for fluorescein and by mass spectrometry a peak at m/z
1938.0471[MH+] was observed for the desired dual peptide.
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Figure 3-15: UV-Vis spectra of FRET-Peptide showed bands at 462 nm for DMAzo
unit and at 485 nm for FITC.

Figure 3-16: Schematic representation of the modified dual labelled peptide design.
To assess the quenching ability of the azo-based modified uracil, the fluorescence of
fluorescein in dual labeled peptide was measured at emission wavelength at 520 nm with
excitation at 488 nm. The FRET-Peptide was subjected to Cat D digestion for 30 min and
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the fluorescence intensity was measured again as shown in (Fig. 3-17), it was found that
the emission intensity was increased by 3.5 fold due to cleavage of the peptide at the
bond between F-F. The digested products were analyzed by MALDI-MS, there was no
sign of undigested substrate peak at m/z 1938.0471 which indicates that the digestion had
gone for completion and moreover a peak at m/z 1103.0483 was observed for the
cleavage product attributed to sequence FRLAXAK as a result of cleavage between the
F-F (Fig. 3-19).
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Figure 3-17: Fluorescence emission spectrum of dual peptide with excitation at 488
nm upon hydrolysis by Cat. D
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Figure 3-18: Mass spectrum of FRET-peptide, Calc. 1938.9478, found 1938.0471
[MH+]
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Figure 3-19: Mass spectrum of FRET-peptide after digestion , Calc. 1103.6627,
found 1103.0463 [MH+]
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3.3

Conclusion

We have synthesized a novel modified azo-based uracil PNA monomer for the utility as a
quencher for PNA-MB design. The synthesized monomer has shown the ability to
quench fluorescien and pyrene emissions. In addition, it was incorporated into in dual
peptide sequence that was used in the evaluation of the activity of Cathepsin D. The azobased PNA monomer may has potential application in photoregulation of hybridization
due to it showed trans-to-cis photoisomerization upon illumination with UV-light (366
nm) and trans isomer was recovered thermally. The synthesized PNA monomer has
showed a characterized spectral change upon changing the pH, this may led to a new type
of pH-indicator based on modified nucleobase.
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3.4

Experimental

5-Diazouracil10
To a cold solution of 5-aminouracil (3.0 g, 23.62 mmol) in
hydrochloric acid 1N (45 mL), a solution of 6.9 % NaNO2 (18 mL)
was added dropwise over a period of 15 min. a pal yellow solid was
precipitated. The reaction mixture was stirred for further 30 min for
complete precipitation. Solid was collected by filtration, wash with iced water and was
dried under vacuum to give (3.12 g, 84%) and used for the next step without further
purification.
5-[4(N,N-Dimethylamino)phenyl)diazenyl]-(1H,3H)-pyrimidine-2,4-dione III-1.
A suspension of 5-diazouracil (2.0 g, 12.8 mmol) in anhydrous
acetonitrile (160 mL) was purged with N2 for 10 min,
borontrifluoride etherate (1.64 mL, 12.8 mmol) and

N-N-

dimethylaniline (1.53 mL, 12.8 mmol) were added to the mixture
and was stirred for 2 h. The separated solid was filtered and refluxed in EtOH (150 mL)
for 1 h. The solid was collected and dried to afford (2.58 g, 80%) of III-1. 1H NMR (400
MHz, DMSO-d6)  : 11.42 (s, 1H), 11.28 (s, 1H), 7.66 (s, 1H), 7.61 (d, J = 8.9 Hz, 2H),
6.79 (d, J = 8.7 Hz, 2H), 3.01 (s, 6H);

13

C NMR (100 MHz, DMSO-d6)  : 161.8, 152.7,

151.3, 143.5, 130.7, 129.5, 124.9, 112.2, 47.6. HRMS (EI): calcd. for C12 H13 N5O2 [M+]
259.1069 found 259.1062
tert-Butyl 2-(5-[(4(N,N-dimethylamino)phenyl)diazenyl)]-2,4-dioxo-3,4-dihydro
pyrimidin-1(2H)-yl)acetate III-2.
To a solution of III-1 (1.0 g, 3.86 mmol) in dry DMF (8 mL),
tert-butyl-2-bromoacetate (0.93 g, 3.86 mmol) and anhydrous
K2CO3 (0.54 g, 3.9 mmol) were added. The reaction was stirred
for 24 h under N2, the solid was filtered through celite, and the
solvent was removed under reduced pressure. The residue was
dissolved in dichloromethane (100 mL) and washed with aqueous saturated Na2CO3 (2 x
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50 mL), brine (50 mL) and dried over Na2SO4. The combined organic solvent was
concentrated under pressure to obtain a yellow oil which was purified via flash
chromatography using ethyl acetate/ hexane as eluting solvents (7: 3, v/v) to yield III-2
as a yellow solid (0.98 g, 74%). 1H NMR (400 MHz, DMSO-d6)  : 11.8 (s, 1H), 8.06 (s,
1H), 7.65 (d, J = 8.4 Hz, 2H), 6.79 (d, J = 8.4 Hz, 2H), 4.52 (s, 2H), 3.02 (s, 6H), 1.41 (s,
9H); 13C NMR (100 MHz, DMSO-d6)  : 167.7, 161.8, 152.8, 150.9, 143.5, 134.6, 129.6,
125.3 112.2, 82.6, 50.51, 28.3. HRMS (EI): calcd. for C18 H23 N5O4 [M+] 373.1750 found
373.1732.
tert-Butyl 2-(5-[(4(N,N-dimethylamino)phenyl)diazenyl)]-2,4-dioxo-3,4-dihydro
pyrimidin-1(2H)-yl) acetic acid III-3.
To a cold solution of III-2 (0.90 g, 2.41 mmol) in dry
dichloromethane (3 mL), TFA (3 mL) was added dropwise,
the reaction mixture was stirred for 4 h at r.t. under N2.
A cold diethylether (15 mL) was added and the mixture kept
overnight at 4 C. The resultant solid was collected by
filteraion, washed with cold doethylether and dried to give III-3 (0.69 g, 90%) as
yellowish brown solid. 1H NMR(400 MHz, DMSO-d6)  : 13.22 (s, br, 1H), 11.78 (s,
1H), 8.07 (s, 1H) 7.65 (d, J = 8.9 Hz, 2H), 6.81 (d, J = 8.9 Hz, 2H), 4.55 (s, 2H), 3.03 (s,
6H); 13C NMR (100 MHz, DMSO-d6)  : 170.1, 161.4, 152.8, 150.9, 143.5, 134.7, 129.6,
125.0, 112.2, 49.8. HRMS (EI): calcd. for C14 H15 N5O4 [M]+ 317.1124 found 317.1121.
tert-Butyl-2-(N-(2-(((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl)-2-(5-[(4-N,Ndimethylamino)phenyl)diazenyl)]-2,4-dioxo-3,4-dihydropyrimid-in-1(2H)yl)acetamido)acetate III-4.
To a cold solution of compound III-3 ( 0.50g, 1.57 mmol) in dry
DMF (7 mL), DCC (0.32 g, 1.57 mmol) and HOBt (0.21 g, 1.57
mmol) were added. The reaction purged with N2 for 15 min then
was stirred for 1h under ambient atmosphere, followed by
dropwise addition of asolution of N-[2-(Fmoc)aminoethyl]
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glycine-t-butyl ester (0.63 g, 1.57 mmol) in dichloromethane (5 mL). The reaction was
stirred under N2 for 24 h, filtered through celite to remove the formed DCU and the
solvent was removed under reduced pressure. The residue was dissolved in
dichloromethane (50 mL), washed with aqueous 5% NaHCO3 (50 mL) (2 x 50 mL), and
brine (50 mL) and dried over Na2SO4. The organic solvents were removed under pressure
and the residue was supjected to flash chomatography using ethylacetate/hexane (7:3,
v/v) as the eluting solvents. The combined fractions was evaporated to give III-4 as
yellow solid (0.72 g, 65% ). Compound III-4 exists in solution as a pair of slowly
exchanging rotamers; signals attributed to major (ma.) and minor (mi.) rotomers are
designated : 1H NMR (400MHz, DMSO-d6)  : 11.76 (s, 1H), 8.09 (s, 1H) 7.89 (d, J =
7.5, 2H), 7.69-7.60 (m, 4H), 7.42-7.32 (m, 4H), 6.78 (d, J = 7.6 Hz, 2H), 4.86 (s, ma.,
1.2H), 4.67 (s, mi., 0.8H), 4.34-4.18 (m, 4H), 3.95 (s, 1H), 3.70 (s, 1H), 3.42-3.39 (m,
2H), 3.27-3.26 (m, 2H), 3.01 (s, 6H), 1.46 (s, mi., 3H), 1.36 (s, ma., 6H); 13C NMR (100
MHz, DMSO-d6)  : 161.1, 156.2, 155.6, 150.7, 143.9, 142.8, 140.7, 130.1, 128.9, 127.6,
126.8, 125.1, 124.3, 120.1, 111.5, 77.6, 72.47, 65.3, 46.7, 36.9, 28.2. HRMS (ESI-TOF):
calcd for C37 H42 N7O7 [MH+] 696.3146 found 696.3107.
2-(N-(2-(((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl)-2-(5-[(4-N,N-dimethyl
amino)phenyl)diazenyl]-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic
acid III-5.
To a cold solution of ester III-4 (0.35 g, 0.5 mmol) in
dichloromethane (2 mL), TFA (2 mL) was added over 10 min. The
reaction mixture was stirred under N2 for 6 h. The solvent was
evaporated in vacuo. The residue was coevaporated with
dichloromethane (4 x 10 mL). The residue was dissolved in
dichloromethane (2 mL), diethylether (5 mL) was added, and the mixture was stored at 4
C overnight, the resulting solid was filtered and dried to afford III-5 as yellow solid
(0.29 g, 89%). Compound III-5 exists in solution as a pair of slowly exchanging
rotamers; signals attributed to major (ma.) and minor (mi.) rotomers are designated : 1H
NMR (400MHz, DMSO-d6) 11.67 (s, 1H), 8.07 (s, 1H) 7.84 (s, ma, 0.6 H), 7.87 (d, J =
7.4 Hz, 2H), 7.83 (s, mi., 0.4 H) 7.65-7.50 (m, J = 7.4 Hz, 4H), 7.38-7.20 (m, J = 7.6 Hz,
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2H ), 7.30 (m, J = 7.6 Hz, 2H), 6.76-6.64 (m, J = 7.6 Hz, 2H), 4.84 (s, 1H), 4.65 (d, J =
7.6 Hz, 1H), 4.31 (d, J = 7.8 Hz, 2H), 4.18-4.11 (m, J = 7.6 Hz, 1H), 3.93 (s, 1H), 3.86
(s, 1H), 3.39 (t, J = 7.8 Hz, 1H), 3.25 (t, J = 7.8 Hz, 1H), 3.01 (s, 6H). HRMS (ESITOF): calcd for C33H34N7O7 [MH+] 640.2520 found 640.2514.
Fluorescnece-quenching studies
Fluorescence measurements were carried out on a Photon Technologies International
Quanta Master 7/2005 spectrophotometer. All the fluorescence titraions are carried out in
ethanol containig 5 M concentarions for pyrene and 8 M for fluorescein. 1 ml of
ethnolic solution of fluorophore was placed in 1cm-fluorescene cell and a small portions
(10 L) of III-3 at 5 M concentartion was added. The emmission spectum was recorded
with excitation wavelength set at 488 nm and monotiring emission signal of fluorescein
at 520 nm and of pyrene at ( 337, 395 and 418 nm).
Crystallography
Crystals of III-2 were grown from a concentrated dichloromethane solution by slow
diffusion of hexane. An orange plate was mounted on a glass fiber. Data were collected
at low temperature (-123 C) on a Nonius Kappa-CCD area detector diffractometer with
COLLECT (Nonius B.V., 1997-2002). The unit cell parameters were calculated and
refined from the full data set. Crystal cell refinement and data reduction were carried out
using HKL2000 DENZO-SMN (Otwinowski & Minor, 1997). The absorption correction
was applied using HKL2000 DENZO-SMN (SCALEPACK). The crystal data and
refinement parameters for III-2 CH2Cl2 are listed in (Table 3-3).
The SHELXTL/PC V6.14 for Windows NT (Sheldrick, G.M., 2001) suite of programs
was used to solve the structure by direct methods. Subsequent difference Fourier
syntheses allowed the remaining atoms to be located. Distinct molecules were formed.
The molecule was very well ordered. The solvent was located on a symmetry element
and was modeled as an anisotropic C and Cl atom. All of the non-hydrogen atoms were
refined with anisotropic thermal parameters. The hydrogen atom positions were
calculated geometrically and were included as riding on their respective carbon atoms.
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Crystal
Empirical formula
Formula weight
Crystal system
Crystal dimensions
Space group
Z
Unit cell dimensions

Collection ranges
Density(calculated)
Temperature
Volume
Denisty (calculated)
Radiation
Absorption coeff.
Absorption correction
F(000)
Theta range for data collection
Observed reflections
Data/restraints/parameters
Final R indices (l > 2σ(l))
R indices (all data)
Goodness-of-fit on F2

III-2
C19 H25 Cl2 N5 O4
458.34
Monoclinic
0.20 x 0.18 x 0.15(mm3)
P 21/n
4
a =13.151(3) Å
b =10.740(2) Å
c =17.188(3) Å
α = 90°
β = 112.31(3)°
γ = 90°
-16<=h<=16; -13<=k<=13; -20<=l<=20
3

1.356 Mg/m
150(2) K
2245.7(8) Å3
1.355(Mg m-3)
Mo Kα (λ = 0.71073 Å)
0.324 mm-1
Multi-Scan
960
1.68to 27.12°
17227
4945/1/271
R1 = 0.1145, wR2 = 0.2453
R1 = 0.0769, wR2 = 0.2124
1.036

Table 3-4: X-ray crystallographic structural parameters for compound III-2.
Synthesis of dual labeled peptide:
Synthesis of the peptide sequence was obtained using preloaded NovaSyn TGR resin
with loading 0.0655 mmol/g on 5 mol scale using the standard FastMoc module on an
Applied Biosystems 433A synthesizer. After synthesis completion, the last Fmoc
protecting group was removed and fluorescein isothiocyanate (FITC) coupling to the Nterminal of the last amino acid was performed manually.
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Peptide labeling with FITC
After completion of the peptide synthesis with uncapped N-terminal, 30 mg (~ 2 mol) of
the resin was transferred to a peptide vessel and resin was washed with dry CH2Cl2 (3
mL), and drained followed by DMF wash (3 mL), and drained. A solution of FITC
(3equiv.) and DIEA (6 equiv) in of dry DMF (1 mL) was added to the resin. Vessel was
shaken for 12 h in the dark at r.t. Completion of FITC coupling was confirmed by Kiesr
test. The dual-labeled peptide sequence was cleaved off and was purified by RPHPLC.The solvent was drained, the resin was washed with dry CH2Cl2 (3 mL) and DMF
(3 mL) and dried.
Cleavage of the peptide from resin
To 20 mg (~ 1.3 mol) of the resin-bound peptide, in a glass vial, of TFA (1 mL) was
added and the mixture was purged with nitrogen and was shaken for 1.5 h. The mixture
was filtered and the resin was rinsed with of TFA (0.5 mL). The combined TFA was
evaporated with a stream of nitrogen to obtain a sticky residue to the glass vial. By the
addition of cold ether (3 mL), an orange precipitate was formed and was collected
through decantation of the ether. The solid was dissolved in 0.05% TFA-H2O (300L),
filtered, and purified by RP-HPLC using a 250 mm x 4.6 mm, C18-bonded phase, 100
pore, 5 μm particle size column. Column was eluted at a flow rate of 1.1 mL/min with the
solvent system: A) TFA (0.05%, v/v) in H2O and B) TFA (0.05%, v/v) in CH3CN with a
binary gradient elution 0-5 min, 100% A; 5-20 min, 100% to 60% A; 20-40 min, 60% to
0%. The collected fractions was lyophilized and was dried to give yellowish-white pellet
which was dissolved in mili-Q water (100 L) and was stored at -4 C.
Hydrolysis of FRET-peptide by Cat D.
The emission spectrum was measured for a sample of the dual peptide (0.1 mol) in
20 mM citrate-phosphate buffer at a pH 4.5 followed by addition of Cathepsin D (0.01
units, ~0.7 g) from bovin spleen, sigma, for digestion. The reaction mixture was
incubated at 40 C for 30 min then was left to cool to room temperature followed by
measuring the emmission of fluorescien signal after digestion.
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Chapter 4
4

Synthesis and Photophysical Studies of Novel photochromic
Phosphoramidite for DNA and RNA

4.1

Introduction

Hybridization of nucleic acids is considered the cornerstone for many biomedical
applications as antigene and antisense. Recently, much effort has been devoted to
controlling DNA functions through external stimuli as light, pH, electric field and heat.
Light is preferred over all other external stimuli due to reasons such as light is efficient,
clean and does not produce any contaminants to the biological system. Light is a
powerful tool to control several bioactive species such as protein, peptides and nucleic
acids.
Photoregulation of nucleic acids is based on covalent attachment of a photoresponsive
molecule to the single-stranded DNA. This process can be achieved by i) introduction of
photolabile protecting groups called caging groups. ortho-Nitrobenzyl group (ONB) is
an example for caging groups that have been widely used in photoregulation of
oligonucleotide and peptides.1 Recently the ONB group has been used for photocontrol of
several biological processes such as gene expression, ribozyme cleavage and RNA
polymerase activity.2a-c In these processes, the ONB group is able to cage substrates and
then release them upon photoirradiation. ONB groups are removed under mild irradiation
with long-wavelength UV radiation (>345 nm) without damaging the biological system.
In this strategy, regulation occurs only once and in one direction. Alternatively, ii) a
photoswichable molecule as azobenzene may be used.3a,b
Photoisomerization of azobenzene has been used to photo-control several molecular
processes. Azobenzene residues were introduced to oligonucleotides via two approaches:
as a side chain on the oligonucleotide phosphate backbone;4a-c and/or as a linker between
two oligonucelotide segments in the main chain of an oligonucleotide.5a,b Inocorporation
of azobenzene as a side chain of the oligonucleotide backbone induces trans-to-cis
isomerization and therfore exerts notable affects on the physicochemical properties and
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on the duplex formation abilities of oligonucleotides. Although, the utility of azobenzene
as a linker has been demonstrated an efficient trans-to-cis photoisomerization, no
successful application has yet been reported.

Figure 4-1: Modified oligonucleotides carrying azobenzene a) in the side chain, b) as
linker.
Introduction of several azobenzene residues to oligonucleotides led to an increase in
melting temperature difference ΔTm corresponding to the photo-induced isomerization.
For example, incorporation of one azobenzene residue into a short 8-mer oligonucleotide
forming a duplex, upon trans-to-cis photoisomerization caused a decrease in ΔTm by
14.3 C, while when two azobenzene residues were incorporated, a decrease in ΔTm by
21.5C was observed. Incorporation of large numbers of azobenzene residues to duplex
structure resulted in deviation of the duplex structure far from the B-form and thusly lost
its ability to interact with proteins.6
Despite the remarkable properties of azobenzenes and its utility in reversible
photoswitching of nucleic acid-related activities, there are some drawbacks arising from
the non-nucleosidic nature of the attached azobenzene. In other words, azobenzene is not
able to form hydrogen bonding with nucleobases and it undergoes stacking interactions
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with the nucleotides that differ from the stacking interaction that occurrs among the
natural nucleotides and consequently led to change in its structural features. Recently, it
was reported that incorporation of azobenzene into DNAzymes and ribozymes lead to
loss of its catalytic activity due to interfering with the active site.7

4.2

Result and discussion

In this work we aimed to synthesize novel photochromic nucleosides for DNA and RNA
synthesis bearing azo-moiety as a solution to circumvent the aforementioned limitations
observed in azobenzene-based oligonucleotides. The synthesized photochromic
nucleosides are characterized by their ability to form hydrogen bonding with nucleosides
obeying Watson-Crick base pairing rules with potential quenching properties based on
the results shown in chapter 3. This goal was achieved by utilizing the naturally occurring
uracil as starting material to maintain hydrogen bonding ability with the complementary
nucleobase adenine (A), and via chemical transformations to introduce phenylazomoiety
to uracil.
As outlined in (Scheme 4-1), the synthetic route to synthesize the azo-uracil
phosphoramidite IV-4 was started with reaction of azo-modified uracil III-1 with
1-chloro-3,5-di-O-p-toluoyl-1,2-dideoxy--D-ribofuranose under basic conditions to
yield the corresponding protected deoxyriboside IV-1 in 63% yield. Removal of the
toluoyl protecting groups was carried out with sodium methoxide in methanol giving the
2-deoxyriboside IV-2 in 79% yield. Standard methods were used to convert the
unprotected nucleosides to 5`-dimethoxytrityl-protected derivative IV-3 by using
dimethoxytrityl chloride (DMTCl) in pyridine giving the product in 63% yield. This was
followed by conversion to the corresponding cyanoethyl phosphoramidite derivative IV-4
in 81 % yield after column chromatography purification.
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Scheme 4-1: Synthesis of uracil phosphoramidite possesses phenylazo moiety for
photoswitching.
To get an access for RNA chemistry, ribonucleoside IV-5 was synthesized as outlined in
(Scheme 4-2) following Vorbrüggen procedure8 starting with refluxing III-1 with
hexamethyldisilazane (HMDS) and trimethylsilyl chloride (TMSCl) to form the
corresponding silylated nucleoside followed by coupling with 1-O-acetyl-2,3,5tribenzoyl--D-ribofuranose in dimethylformamide (DMF) in the presence SnCl4 to
afford IV-5 in 71% after column chromatography purification. Removal of benzoyl
groups was carried out by ammonia in methanol to yield azo-based riboside IV-6 in 86%
yield.
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Scheme 4-2: Synthesis of photochromic riboside.

4.2.1

Photoisomerization studies

Azobenzene is well known to photoisomerize from its planar trans isomer to the nonplanar cis isomer after UV-light irradiation (300nm ~ 400nm), and back to the tranisomer upon irradiation with visible light (> 400nm) or thermally. This process is
completely reversible under UV and visible irradiations. Based on this observation, the
the synthesized nucleosides carrying 4-(N,N-dimethylamino)azophenyl moiety are
expected to follow the same behavior that azobenzene follows as demonstrated in (Fig.
4-2).

Figure 4-2: Schematic representation of reversible trans-cis photoisomerization
of the photochromic nucleoside IV-2 and IV-6.
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To assess the photochromic behaviour of the synthesized nucleosides IV-2 and IV-6 by
monitoring the changes that may occur at their absorption with response to irradiation.
As can be seen from (Fig. 4-3), the absorption spectrum of trans isomer has a major
peak centered at 454 nm (in dichloromethane for IV-2) and at 443 nm (in acetonitrile
for IV-6) attributed to strong -* transition which overlapped with the weak peak
attributed to weak n-* transition. By irradiating with UV-light at 366 nm, a decrease
in the intensity of the absorption band was observed along with the irradiation time due
to trans-to-cis isomerization, while the reverse cis-to-trans isomerization was achieved
via thermal relaxation.
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Figure 4-3: Absorption spectra of A) IV-2 in ethanol and B) IV-6 in
acetonitrile at 10 M concentrations for trans-to-cis photoisomerization upon
illumination with UV-light at 366 nm.
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4.2.2

pH-Sensitivity

Azobenzenes

derivatives

especially

aminoazobenzene

and

4-(N,N-dimethyl-

amino)azobenzene attracted much attention due to their ability to change colour in
solution with the changing of the pH. It is well established that protonation of
aminoazobenzene derivatives led to the formation of two tautomeric azonium and
ammonium forms.9a,b The azonium ion is obtained by protonation on azo-nitrogen
leading to delocalized of the lone-pair electrons of the aromatic ring and as
consequence a red shift in absorption maximum was occurred. Ammonium ion is
obtained by protonation at amino-nitrogen resulting in prevention the conjugation of
electrons lone-pairs and thusly the UV-Vis spectrum looks similar to that of
unsubstituted azobenzene due to diminish the effect of amino substituent.

Figure 4-4: Structure of 4-(N,N-dimethylamino)azophenyl(deoxy)uridine
and its protonated forms. Sugar was removed for simplicity.
As mentioned in chapter 3, the presence of an azo- and dimethylamino groups in the
synthesized nucleosides promoting us to study the effect of acid. We investigated the
effect of trifluoroacetic acid solution (0.005 M) in dichloromethane and ethanol on the
nucleosides IV-2 and IV-6 respectively. Matazo and coworkers10 have studied the
effect of acid on 4-(N,N-dimethylamino)azobenzene, they observed that absorption
band appears at max 411 nm in acetonitrile which is attributed to neutral trans 4-(N,Ndimethylamino)azobenzene, upon protonation this band was red shifted to max 535 nm
with appearance of absorption band at max 318 nm. They have assigned the two bands
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to the azo-protonated (azonium) and amino protonated (ammonium) of trans-4-(N,Ndimethylamino)azobenzene, respectively, based on quantum-chemical calculations and
resonance Raman spectra.
Similarly, as can be seen in (Fig. 4-5), upon addition of TFA solution to deoxyriboside
IV-2 in dichloromethane leads to a decrease in the -* absorption band at max 455 nm
which is attributed to the neutral form with an increase in -* absorption bands
centered at 618 and 350 nm attributed to azonium and ammonium ions respectively.
There are two isosbestic points were observed at 376, 507 nm indicate that IV-2 exists
either as non-protonated or protonated species in tautomeric equilibrium. While, upon
titrating of IV-6 with small aliquots of TFA in ethanol, the -* absorption band for
neutral form at max 436 nm was decreased with appearance of new absorption bands
centered at 623 and 342 nm attributed to the protonated forms azonium and ammonium
ion respectively. These results are in excellent agreement with the aforementioned
study. Surprisingly, subjecting solutions of IV-2 and IV-6 in halogenated solvents as
dichloromethane or chloroform to TFA leads to colour change from yellow to deep
blue colour while using solvents as ethanol, methanol, and ethyl acetate instead this
colour change was not observed.
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Figure 4-5: Changes in UV-Vis spectra of A) IV-2 and C) IV-6 upon addition of
increasing concentrations of TFA, arrows indicate the progressive decrease of
absorption band for neutral form and the growth of protonated form. B, D)
Variation of absorbance vs TFA concentration for the respective absorption bands.
4.3

Conclusion

We have successfully designed and synthesized novel photochromic azo-based
nucleosides. These nucleosides showed the ability to undergo trans-to cis isomerization
upon irradiation with visible light at 366 nm and reversibly the trans configuration was
recovered thermally in the dark. In addition, the synthesized photochromic nucleotides
showed halochromic effect upon acid treatment. Therefore, they may be contributing in
photoregulation of nucleic acids. To the best of our knowledge, this is the first example
of azo-based (deoxy)uridine derivatives posses intrinsic photoswitching property.
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4.4

Experimental

General consideration. All solvents and chemicals were commercially available and
were used as purchased. Reactions were monitored by thin layer chromatography (TLC)
on pre-coated 0.2 mm Merck Kieselgel 60 TLC plates. Silica gel 60 F254 (Merck) plates
and visualized with an ultraviolet light source at 254 nm. Silica gel (Merck Kieselgel 60,
15-40 mm) was used for column chromatography.

1

H NMR,

13

C NMR and

31

P NMR

spectra were recorded at a Varian Mercury Plus spectrometer (400.09 MHz, 100.61MHz
and 242.9 MHz respectively) at room temperature. Chemical shifts are reported in parts
per million (δ), were measured from tetramethylsilane (0 ppm) and are referenced to the
residual proton in the deuterated solvent: CDCl3 (7.26 ppm), DMSO-d6 (2.48 ppm),
CD3OD (2.04 ppm) for 1H NMR and CDCl3 (77.0 ppm), DMSO-d6 (39.5 ppm) and
CD3OD (49.1) for

13

C NMR. Multiplicities are described as s (singlet), d (doublet), m

(multiplet), and br s (broad singlet). Coupling constants (J) are reported in Hertz (Hz).
5-[4-(N,N-Dimethylamino)phenyl]diazenyluracil III-1
To a cold solution of 5-aminouracil (1.0 g, 7.87 mmol) in
hydrochloric acid 1N (15 mL), a solution of 6.9% NaNO2 (6 mL)
was added dropwise over a period of 15 min. a pal yellow solid
was precipitated. The reaction mixture was stirred for further 30
min for complete precipitation. Solid was collected by filtration, wash with iced water
and was dried under vacuum to give 5-diazouracil (1.04 g, 84%) and used for the next
step without further purification. A suspension of 5-diazouracil (0.5 g, 3.2 mmol) in
anhydrous acetonitrile (50 mL) was purged with N2 for 10 min, borontrifluoride etherate
(0.41 mL, 3.2 mmol) and N,N-dimethylaniline (0.38 mL, 3.2 mmol) were added to the
mixture and was stirred for 2 h. The separated solid was filtered and refluxed in EtOH
(100 mL) for 1 h The solid was collected and dried to afford (1.38 g, 80%) of IV-1. 1H
NMR (DMSO-d6)  : 11.42 (s, 1H), 11.28 (s, 1H), 7.66 (s, 1H), 7.61 (d, J = 8.9 Hz, 2H),
6.79 (d, J = 8.7 Hz, 2H), 3.01 (s, 6H);

13

C NMR (DMSO-d6)  : 161.8, 152.7, 151.3,

143.5, 130.7, 129.5, 124.9, 112.2, 47.6. HRMS (EI): calcd. for C12 H13 N5O2 [M+]
259.1069 found 259.1062.
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5-[(4-(N,N-dimethylamino)phenyl)diazenyl]-3, 5-di-O-(p-toluoyl)-2-deoxyuridine
IV-1
To a suspension of 5-((4-(N,N-dimethylamino)phenyl)diazenyl)
uracil (0.44 g, 1.72 mmol ) in dry THF (20 mL), NaH (60%
dispersion in mineral oil, 82 mg, 3.44 mmol) was added and stirred
at r.t. for 2 h. A solution of 1--Chloro-3,5-di-O-toluoyl)-2deoxyribose (0.69 g, 2.23 mmol) in dry THF (5 mL) was added to
the mixture in one portion and the reaction mixture was stirred for 24 h under an
atmosphere of N2. Solvent was evaporated under vacuum and the residue was dissolved
in dichloromethane (30 mL), was washed with saturated aqueous sodium Na2CO3, brine
and dried over anhydrous Na2SO4. The solution was filtered, concentrated, and the
residue was subjected to purification by flash chromatography with CH2Cl2/CH3OH
(20:1, v/v) as eluent to give bis-toluoyl ester IV-1 as red solid. The product was obtained
as a mixture of two isomers (0.65 g, 63%). 1HNMR (DMSO-d6) : 11.78 (br s, 1H), 8.02
(s, 1H), 7.92-7.89 (m, 2H), 7.80 (d, J = 7.8 Hz, 1H), 7.68 (d, J = 8.2 Hz, 1H), 7.50 (d, J =
8.9 Hz, 1H), 7.37-7.33 (m, 3H), 7.16 (d, J = 8.2 Hz, 1H), 6.91 (d, J = 8.2 Hz, 1H), 6.75
(d, J = 8.9 Hz, 1H), 6.69 (d, J = 9.3 Hz, 1H), 6.32 (m, 1H), 5.57 ( d, J = 5.8,1H), 5.01
(m, 1H), 4.57 (m, 1H), 4.41 (m, 1H), 3.02 (s, 6H), 2.97 (m,1H), 2.61 (m, 1H), 2.37 (s,
3H), 2.26 (s, 3H); 13C NMR (CDCl3)  : 166.1, 165.7, 152.2, 144.3, 143.5, 129.8, 129.6,
129.1, 126.5, 126.6, 126.3,125.7, 111.2, 87.9, 77.3, 74.6, 64.1, 40.1, 27.96. HRMS (EI):
calcd. 611.2380 for C33H33N5O7 [M+] found 611.2391.
5-[4-(N,N-dimethylamino)phenyl)diazenyl]-2-deoxyuridine IV-2.
To a cold solution of the toluoyl ester IV-1 (0.5 g, 0.82 mmol) in dry
CH2Cl2 (5 mL), NaOMe solution (0.2 M in MeOH) (9.8 mL, 1.96
mmol) was added dropwise over 15 min. The reaction mixture was
stirred at r.t. for 1 h. An aqueous solution of 5% NH4Cl was added to
the mixture till the pH was 8 and the mixture was extracted with
ethylacetate (3 x 30 mL). The combined organics were washed with brine, dried over
anhydrous Na2SO4 and concentrated under reduced pressure to afford red oil residue. The
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residue was subjected to flash chromatography using hexane/ CH2Cl2 (70:30, v/v) as the
eluent to yield the deoxyriboside IV-2 as red powder (0.25 g, 79%). 1H NMR (CD3OD)
: 8.50 (s, 1H), 7.79 (d, J = 7.8 Hz, 1H), 6.77 (d, J = 7.8 Hz, 1H), 6.33 (t, J = 6.5 Hz,
1H), 4.43 (m, 1H), 3.96 (m, 1H), 3.83 (m, 1H), 3.75 (m, 1H), 3.20 (dd, J = 3.3 and 7.3
Hz, 1H), 3.03 (s, 6H), 2.40 (m, 2H);

13

CNMR (CD3OD): δ 163.5, 154.3, 151.5, 131.2,

126.4, 112.7, 89.3, 87.4, 72.1, 62.7, 41.8, 40.5. HRMS (EI): calcd. 375.1543 for
C17H21N5O5 [M+] found 375.1535.
5-[4-(N,N-dimethylamino)phenyl)diazenyl]-2-deoxy-5-O-(p, p-dimethoxytrityl)
uridine IV-3
The free nucleoside IV-2 (0.2 g, 0.54 mmol) was dried by
coevaporation with dry pyridine (3 x 5 mL) and then was
dissolved in dry pyridine (10 mL). A solution of 4,4´-dimethoxytritylchloride (0.269 g, 0.69 mmol) in dry pyridine (5 mL) and
DIPEA (7.0 mmol, 1 mL) was added and the mixture was stirred
at r.t. for 3 h. The reaction mixture was quenched by the addition of methanol (2 mL),
was diluted with CH2Cl2 (75 mL) and then was washed with saturated aqueous solution
of NaHCO3 (3 x 50 mL). The organics were combined, dried over anhydrous Na2SO4 and
filtered. The solvent was removed under reduced pressure to give red oil. The crude
product was purified by flash column chromatography using CH2Cl2/ MeOH/ Et3N (85:
10: 5, v/v) as elution solvent afforded the tetritylated derivative IV-3 as red solid (0.28 g,
63%). 1H NMR (CDCl3) δ: 8.25 (s, 1H), 7.65 (d, J = 8.9 Hz, 2H), 7.38 (d, J = 7.4Hz, 2H),
7.27 (d, J = 7.4 Hz, 4H), 7.22 (d, J = 7.0 Hz, 2H ), 7.14 (m, 2H), 6.78 (d, J = 8.5 Hz, 3H),
6.51 (d, J = 8.5 Hz, 2H), 6.18 (m, 1H), 4.57 (m, 1H), 4.39 (m, 1H), 3.69 (s, 6H), 3.20 (m,
1H), 3.25 ( m, 1H), 2.90 (s, 6H), 2.80 (m, 1H) 2.47 (m, 1H); 13C NMR (CDCl3) δ: 161.4,
158.3, 152.0, 149.7, 144.5, 143.3, 135.6, 135.39, 130.4, 129.8 , 127.9, 127.7, 126.6,
125.0, 113.0, 111.1, 89.1, 86.2, 71.9, 64.1, 55.0, 45.6, 40.0. HRMS (ESI): calcd.
678.2928 for [MH+] C38H40N5O7 found 678.2906.
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5-[4-(N,N-dimethylamino)phenyl)diazenyl]-2-deoxy-3-(2-cyanoethyldiisopropyl
phosphoramidite)-5-O-(p,p-dimethoxytrityl)uridine IV-4
To a solution of DMT-deoxyuridine IV-3 (0.16 g, 0.24 mmol) in
dry CH2Cl2 (5 mL), DIPEA (340 μL, 2.4 mmol), 2-cyanoethyl(N,N-diisopropylamino) chlorophosphite (105 μL, 0.47 mmol) was
added. The reaction mixture was stirred at r.t. under ambient
atmosphere for 3 h until deemed complete by TLC. Solvent was
removed and the resultant residue was dissolved in CH2Cl2 (25
mL), washed with aqueous solution of 5% NaHCO3 (25 mL), brine (20 mL) and was
dried over anhydrous Na2SO4. After removal of solvent the crude product was subjected
to flash chromatography using hexane/ ethylacetate/ Et3N (80:15: 5 to 50:45:5, v/v) to
yield the phosphoramidite derivative IV-4 (0.169 g, 81%). 1H NMR (CDCl3) δ : as two
diastereomers: 8.19 and 8.17 (2s, 1H), 7.77 (d, J = 7.6 Hz, 2H), 7.38 (d, J = 7.6 Hz, 2H),
7.21 (m, 7H), 6.79 (d, J = 6.7Hz, 4H), 6.63 (d, J = 6.5 Hz, 2H), 6.29 (m, 1H), 4.80 (m,
1H), 4.54-4.46 (m, 2H), 3.75 (s, 6H), 3.57-3.48 (m, 2H), 3.03 (s, 6H), 3.38 (m,1H), 3.11
(m, 1H), 2.85 (m, 2H), 2.38-2.17 (m, 2H), 1.20 (s, 12H);

13

C NMR (CDCl3) δ : 160.8,

158.5, 152.3 149.5, 144.3, 143.5, 135.5, 129.9, 128.0, 126.9, 125.1, 113.2, 111.2, 88.7,
85.5, 74.1, 67.1, 55.0, 43.0, 40.2, 32.2, 29.6, 26.3, 24.4, 23.38; 31P NMR (CDCl3): δ two
diastereomeric peaks at 149.2 and 148.6. HRMS (ESI): calcd. 878.3880 for [MH+]
C46H55N8O8P, found 878.3889.
5-[(4-(N,N-dimethylamino)phenyl)diazenyl]-1-(2, 3, 5-tri-O-benzoyl--Dribofuranosyl)]uridine IV-5
A suspension of 5-((4-(N,N-dimethylamino)phenyl)diazenyl)uracil
III-1 (0.26 g, 1 mmol) in of 1,1,1,3,3,3-hexamethyldisilazane
(HMDS) (20 mL) and of trimethylsilyl chloride (1 mL) was
refluxed until a clear solution was obtained. The solution was
allowed to cool, and excess HMDS was removed under reduced
pressure. The silylated uracil derivatives were dissolved in CH3CN (5 mL) and the
solution was burged with nitrogen for 15 min prior to addition of SnCl 4 (10% excess)
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(127 L, 1.2 mmol) to the reaction mixture with vigorous stirring. A solution of 1-Oacetyl-2,3,5-tri-O-benzoyl--D-ribofuranose (0.56 g, 1.1 mmol) in CH2Cl2 (20 mL) was
added dropwise to the reaction mixture. The solution was stirred at r.t. for 6 h at which
the reaction came to completion as determined by TLC. The reaction mixture was
quenched by aqueous saturated NaHCO3 solution (100 ml) and was extracted with
CH2Cl2 (3 x 50 ml) and was dried over anhydrous Na2SO4. The solvent was removed
under reduced pressure leaving brown residue. The crude product was purified by flash
column chromatography using elution with a gradient of hexane/ CH2Cl2 (from 100:0 to
60:40, v/v). Compound IV-5 was isolated as a red solid (0.5 g, 71%). 1H NMR (CDCl3)
: 9.86 (br s, 1H), 8.05 (s, 1H), 7.96 (d, J = 7.4, 2H), 7.91 (d, J = 7.0, 2H), 7.70 (d, J =
7.4, 3H), 7.49 (m, 4H), 7.32 (m, 6H), 6.66 (d, J = 7.0, 2H), 6.29( m, 1H), 4.82 (m, 1H),
4.72 (m, 3H), 3.06 (m, 1H), 3.03 (s, 6H);

13

C NMR (CDCl3) δ: 166.2, 165.3, 160.6,

152.7, 149.4, 143.4, 133.8, 133.4, 129.9, 129.8, 128.5, 125.5, 111.2, 88.6, 80.9, 74.2,
71.5, 64.2, 40.2. HRMS (ESI): calcd. for C38 H34 N5O9 [MH+] 704.2357 found 704.2358.
5-[(4-(N,N-dimethylamino)phenyl)diazenyl]uridine IV-6
Compound IV-5 (0.4 g, 0.57 mmol) was dissolved in saturated
solution of ammonia in methanol (20 mL) and was stirred for 4 h
at r.t. The solution was evaporated under pressure to give the crude
product which was purified by flash column chromatography using
CH2Cl2/MeOH (90: 10,v/v) yielding 0.19 g (86%). 1H NMR
(DMSO-d6) : 7.73 (s, 1H), 7.64 (d, J = 8.9, 2H), 6.78 (d, J = 8.9, 2H), 6.14 (m, 1H),
5.07 (m, 1H), 4.90 (m, 1H), 4.62 (m, 1H) (Exchangeable 3OH), 4.52 (m, 1H), 4.12 (d, J =
5.4, 1H), 3.69 (m, 1H), 3.62 (m, 2H), 3.44 (m, 1H), 3.01 (s, 6H); 13C NMR (DMSO-d6)
δ: 160.8, 152.5, 143.2, 124.8, 111.9, 94.9, 84.9, 71.4, 70.6, 63.7, 62.79, 40.5. HRMS
(ESI): calcd. for C17H21N5NaO [M+] 414.1390 found 414.1382.
UV-Vis measurments:
All UV-Vis spectra were measured with a Varian Cary 300 Bio spectrophotometer using
quartz cuvette cells of 1 mm of optical path.
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Photoisomerization.
Trans-to-cis photoisomerization of nucleosides IV-2 and IV-6 were monitored by UVVis spectroscopy. A solution of the nucleosides at 1.06 x10-5 M concentration (IV-2 in
dichloromethane) and (IV-6 in acetonitrile) were irradiated with UV-light at room
temperature using a UVGL-58 hand held lamp (6 watt, 366 nm) at A distance of
approximately 5 cm. The spectral change for absorption maximum peak at 455 nm (for
IV-2) and 436 nm (for IV-6) were monitored with the time course of irradiation. While
the cis-to-trans isomerization was achieved and confirmed by retrieving the maximum
absorption bands at 455 nm (for IV-2) and 436 nm (for IV-6) thermally by leaving the
samples at the dark at room temperature.
Effect of acids
The spectral change of the synthesized photochromic nucleosides at concentration
6.2x10-6 M (in dichloromethane for IV-2) and 1.5x 10-5 M (in ethanol for IV-6) were
monitored upon addition of small aliquots of TFA solution (0.005 M).
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Chapter 5
5

Synthesis of Acridine-Based PNA Monomer Suitable for
PNA-Fluorescent Probes.

It is well known that the stability of nucleic acid double helical structure (DNA:DNA,
DNA:RNA, PNA:DNA, PNA:RNA and PNA:PNA) relies on many intermolecular
interactions such as hydrogen-bonding between nucleotides, -stacking interactions,
solvent effect.

5.1

Hydrogen bonding

Generally, a hydrogen bond is formed between hydrogen atom covalently attached to an
electronegative atom (donor atom) and an electronegative atom (acceptor). In
nucleobases H-bonds mainly form between N-H····N or/and N-H····O of complementary
nucleotide base pairs. H-bond formation mechanistically can be described by interactions
of lone-pair orbitals on O or N of one nucleobase with * orbital of N-H.1 Despite the Hbond being very weak compared to covalent bonds, formation of many H-bonds between
complementary nucleotides in two DNA strands is sufficiently strong enough to keep the
two DNA strands in duplex structure.
Several reports show that the stability of the nucleic acid structures benefit from
increasing the number of hydrogen bonds sites in nucleobases. Simply, this can be
achieved by modifying naturally occurring nucleobases. Diaminopurine (DAP), an
adenine analogue, is characterized by its ability to pair with thymine by three hydrogen
bonds (only two hydrogen bonds between A:T) (Fig. 5-1).

Figure 5-1: Base pairing between DAP:T comparing to A:T .
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Another example was introduced from our lab is (mono-ortho-(aminoethoxy)phenyl)
pyrrolocytosine (moPhpC). This modified cytosine is able to base pairing with guanine
by formation of four hydrogen bonds. The design of moPhpC is characterized by the
extending aromatic ring system of pyrrolocytosine that will improve -stacking in
addition to presence of aminoethoxy linker that provides a new site for formation of Hbonds with O(6) of guanine via Hoogsteen base pairing. Incorporation of moPhpC into a
10-mer PNA with the sequence GTAGATXACT-Lys (X= moPhpC) resulted in an
increase in the stability of DNA and RNA duplexes by (+10.5C) and (+4 C),
respectively, which was rationalized by the formation of an additional hydrogen bond to
guanine (Fig. 5-2).2

Figure 5-2: Hybridization of cytosine (left) and its modification moPhpC (right)
with guanine to demonstrate the effect of increasing of H-bonds on the stability of
duplex.

5.2

Base-stacking

In base stacking there are no covalent interactions between the nucleobases in a dsDNA
structure. In most of all known DNA structures the bases are found to have face-to-face
interaction due to their planar structure. There are many factors affecting -stacking such
as Van der Waals dispersive forces between bases, permanent electrostatic effects of
interacting dipoles and solvation effects.3 A number of studies have proved base-stacking
contributes significantly to the stabilization of DNA and RNA helical structure. For
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example, Turner and coworkers4 have found that double-helical structure of short RNA is
stabilized by introducing unpaired base at the end. This study was based on the
dangling-end effect.

5.3

Fluorescent nucleobases

Since 1980’s, much effort has been devoted to exploit using fluorescence techniques in
detection of nucleic acids. Aromatic-based amino acids (phenylalanine, tyrosine and/or
tryptophan) are characterized by their intrinsic fluorescence that may be used in
fluorescent studies; but natural nucleic acids are known to be nonfluorescent.5a,b Due to
the promising results shown for detection of nucleic acid using fluorescent probes,
intensive research has been devoted to design and synthesize nucleobases possessing
fluorescent properties. There is a great demand for such nucleobases, especially ones that
are fluorescent while maintaining the hydrogen bonding ability to the complementary
nucleobases.
Fluorescent nucleobases are classified by Tor6 into five major families as 1) isomorphic
base analogues, 2) pteridines, 3) Expanded nucleobases, 4) chromophoric base analogues
and 5) conjugated base analogues. In the following paragraphs a brief details are given
for each family.
1) Isomorphic base analogues, heterocyclic compounds characterized by its similarity to
the natural nucleobases in overall dimension and their ability to Watson-Crick base
pairing. The most common example of this class is 2-aminopurine (2-AP). 2-AP is an
analog of guanine and adenine and therefore it can pairs with thymine and uracil obeying
Watson-Crick7 base pairing and with cytosine by Wobble base pairing8 as shown in
(Fig.5-3). 2-AP is distinguished by its high fluorescence quantum yield (F = 0.68 in
aqueous solution) and high sensitivity to the local environment. Upon incorporation of 2AP into nucleic acid, the fluorescence intensity of 2-AP was drastically reduced ~ 100
times due to stacking interactions with nearest neighbor nucleobases. This reduction in 2AP quantum yield is highly dependent on base sequence.9 Owing to 2-AP sensitivity to
microenvironment, it has been widely used in several studies of nucleic acid structure and
dynamics within DNA,10 and RNA.11
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Figure 5-3:Represntation of hybridization of 2AP with natural base complements
thymine and cytosine.

2) Pteridines, purine analogues, are bicyclic planar

compounds formed from two

condensed six membered rings and are distinguished by their ability to form hydrogen
bonds with complementary bases in addition to their intensive emission quantum yield
(F = 0.77-0.88 for adenosine analogues and 0.39-0.48 for the guanosine)12 (Fig. 5-4).
Pteridines have been employed in numerous applications as hybridization probes which
are used in measuring the cleavage activity of the retrovirally coded protein, human
immuneodeficiency virus-1 (HIV-1) integrase (IN).13 Another example of using pteridine
probes (using 6MAP as replacement of A-residues) in detection of A-tract structure.14

Figure 5-4: Strcutures of some pteridine derivatives.
3) Expanded nucleobases, are natural nucleobases that have been extended with fused
aromatic rings. Etheno-A,15 the simplest example of fluorescent extended nucleobases
with quantum yield = 0.54 (in dioxane-H2O 1:1), it was prepared by reaction of
chloroacetaldehyde with adenosine. Despite the fluorescence property of Etheno-A, it can
not engage in hydrogen bonding. Much work has been done to extend the nucleobases
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structures while retaining their ability to hydrogen bond with complementary nucleobases
(Fig.5-5).16

Figure 5-5: Examples of expanded nucleobases.

4) Chromophoric base analogues, are produced when the natural nucleobases are
replaced by hydrocarbons and heterocyclic residues that are characterized by their
emission such as pyrene, phenanthrene, terphenyl, terthiophene, benzoterthiophene and
coumarin (Fig. 5-6).17 Using multiple dyes as replacement of DNA bases in adjacent
position in a DNA sequences can be used in detection of genetic sequence. For example,
pyrene is a well-characterized excimer-forming fluorophore. When it is used alone it
emits blue light while using two units of pyrene leads to emission of green light ascribed
to the formation of an excimer complex through energy transfer from one pyrene unit to
the other. Kool and coworkers18 have exploited this colour change of pyrene upon
excimer complex formation in detection of a portion of a gene. This was achieved by
synthesis of two single pyrene-labeled strands at 3` and 5` ends and these strands were
designed to be a complementary to a portion of the gene under study. Upon hybridization,
the two pyrene units are located in adjacent position and thusly change fluorescence
colour due to formation of excimer.
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Figure 5-6: Examples of hydrocarbons and heterocyle DNA base replacement.

5) Conjugated base analogues, are the fluorescent aromatic residues that are conjugated
to the nucleobases via a linker. This class is characterized by introducing fluorecent
property from the aromatic residue and maintaining the hydrogen bond ability with their
complementary nucleobase. 5-alkynyluracil derivatives19a-f are good examples of this
class were reported by several groups their synthesis is based on Sonogashira cross
coupling reaction. Hudson and coworkers19a have exploited mismatch detection by
5-ethynyldeoxuridine derivatives, it was found that the greatest fluorescence response (6
fold increase in fluorescence intensity with matching sequence) was observed for the
oligomer containing p-methoxyphenylethynyluracil unit (Fig. 5-7).
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Figure 5-7: Structures of some conjugated base analogues used in DNA and RNA
probe.

5.4

Acridine

Acridine is a heterocyclic analog of anthracene where the central CH group is replaced by
nitrogen atom as shown in (Fig 5-8). Acridine derivatives have been known since 19th
century but they have attracted much interest after World War I when they were used as
antibacterial and antimalarial agents.20,21
Acridine derivatives have been employed for targeting several biological targets as
topoisomerases I and II, telomerase/telomere and protein kinases.22 The biological
activity of the acridines is mainly ascribed to their planar configuration that allow them y
to intercalate within the double-stranded DNA structure leading to interference with the
cellular machinery.
Several acridine-based drugs are reported in literature proved their ability as anticancer,
antibacterial and antimalarial agents. For example, Amsacrine (m-AMSA), was designed
by Denny and coworkers23 and it was the first drug has been proved to bind with topo II-
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DNA complex by intercalation.24 Chourpa and coworkers25 confirmed by using surfaceenhanced Raman scattering (SERS) spectroscopy that the side chain located at the metaposition participates in an additional specific interaction with topo II-DNA complex. It is
well established that acridine derivatives can bind to DNA and RNA through
intercalation of the acridine ring between adjacent base pairs in the DNA duplex.26-a-c
Acridine units are held in their positions by: 1) strong ionic bonds

between the

protonated acridine-nitrogen atoms and the phosphate ions of DNA backbone and 2) van
der Waals forces between acridine unit and the base pairs.

Acridine derivatives have been extensively used for labeling oligonucleotide probes,
acridine orange (AO) is an example of fluorescent acridine derivative which is also
characterized by its affinity to nucleic acids. In aqueous solution, AO has been shown to
exist in two forms: 1) one is distinguished by an absorption maximum band at 494 nm
and green fluorescence maximum band at 530 nm this form was found in highly-diluted
solutions (10-7 M) attributed to presence of acridine as single monomers. 2) the other
form is characterized by an absorption maximum band at 465 nm and red fluorescence
maximum band at 640 nm this form was found in highly-concentrated solutions (> 10-2
M) this is ascribed to presence of acridine as dimers.27 AO was used for discriminate
between dsDNA and ssDNA through enhancement of fluorescence upon dsDNA binding
whereas AO intercalates into dsDNA while it binds to ssDNA electrostatically.28

Figure 5-8: Structure of acridine, m-AMSA and acridine orange (AO).
Based on the aforementioned properties of either acridine as a fluorogenic molecule or
peptide nucleic acid (PNA) as artificial nucleic acid analog with remarkable binding
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ability, we interested in synthesis of PNA monomer possessing acridine moiety.
Incorporation of acridine-based PNA monomer in PNA oligomer may be used as reporter
probe for DNA detection in addition to its potential stabilization of duplex structure.

5.5

Results and discussion

The synthesis of the acridine-based PNA monomer is illustrated in (Scheme 5-1). Started
with the synthesis of 9-chloroacridine (V-1) from N-phenylanthranilic acid and
phosphoryl chloride according to the reported method.29 In the next step, 9-chloroacridine
was refluxed with 5-aminouracil in the presence of phenol to afford 5-(acridin-9ylamino)uracil V-2 in 85% yield. The ethyl ester derivative V-3 was obtained in 65%
yield by alkylation of V-2 at N-1 position with 2-ethyl bromoacetate in DMF in the
presence of anhydrous K2CO3. V-3 underwent hydrolysis using aqueous NaOH (2.5 M)
in THF to give the acetic acid derivative V-4 in 93%. Carbodiimide mediated coupling of
V-4 with N-[2-(Fmoc)aminoethyl]glycine-t-butyl ester was accomplished using
EDC/HOBt, to give the protected monomer ester V-5 in 71 % yield. Finally, removal of
t-butyl group was carried out by acidolysis using TFA to give the acridine-containing
PNA monomer V-6 in 90% yield.

Scheme 5-1: Synthesis of acridine-based PNA monomer.
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5.5.1

Photophysical properties

UV-Vis spectra of acridine-based PNA monomer have been investigated under different
solvents (Table 5-1), there is no clear trend between solvent polarities to the absorption
maximum of V-6. It is well established that acridine moity is amenable for protonation
forming acridinum cation (AcH+). The effect of acid on comound V-6 has been
investigated by UV-Vis as shown in (Fig 5-1). Treatment of V-6 in various solvents with
trifluoroacetic acid casued a red shift of the maximum absorption band, interstingly this
shift was accopained by an increasing of the absorption intensity.

Solvent

DCM

max (Neutral) nm

dioxane Acetone EtOH

404

406

412

max (Protonated) nm 434, 443 427,443

409

430,453

CH3CN
402

417, 437 418, 433

Table 5-1: Photophysical properties of V-6
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Figure 5-9: UV-Vis spectrum of V-6 (2.6 M) neutral and acidic form in a) CH3CN
and b) Dioxane
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5.5.2

Fluorescence properties of acridine-based monomer

A preliminary fluorescence study on compound V-6 has been obtained, the acridinebased PNA monomer showed a high quantum yield of 0.32 in ethanol and 0.43 in
dichloromethane. A drastic decrease in the fluorescence emission is observed upon
increasing water content as shown in (Fig. 5-10). The quenching behaviour is a good
indication for the potential use of PNA probe contacting acridine moiety in monitoring
binding events.
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Figure 5-10: Quenching of fluorescence emission of V-6 in EtOH upon addition of
water.

5.5.3

Future work

Incorporation of acridine-based PNA monomer into PNA oligomer is underway. This
PNA oligomer may be used as reporter probe. Based on the fluorescence quenching of
acridine upon subjecting to aquouse environment, the acridine containing PNA prob may
be used to monitor the state of hybridization (single stranded or duplex structure)

5.5.4

Conclusion

We synthesized PNA monomer carrying acridine moiety characterized by its high
fluorescene quantum yield that may be used as reported in PNA probes with expected
stabilization of the formed duplex structure. It was found that emission of acridine is
sensitive to aqueous environment which indicates that PNA probe containing acridine
moiey may be a good candidate for reporting binding events.
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5.6

Experimental

9-Chloroacridine V-1
In a round bottom flask fitted with a water condenser, N-phenylanthranilic
acid (2.0 g, 9.39 mmol) was suspended in POCl 3 (20.0 g, 47 mmol), the
mixture was heated slowly for 15 min on water bath at 80 C, the reaction
mixture was transferred to oil bath and heated for 2 h at 120 C. The excess of POCl3 was
removed by distillation under vacuum leaving the residue. Cold water (200 mL) was
added and the residue was basified with concentrated NH4OH solution (28%, 15 mL) to
afford the product as greenish gray solid (1.8 g, 90%). 1H NMR (DMSO-d6) δ: 8.40 (dd, J
= 2.2 and 0.7, 1H), 8.38 (dd, J = 2.2 and 0.7, 1H), 8.21 (dd, J = 1.8 and 0.6, 1H), 8.19
(dd, J = 1.8 and 0.6, 1H), 7.95(d, J = 1.4, 2H), 7.92 (d, J = 1.8 and , 2H). HRMS (EI):
calcd. for C13H8ClN [M]+ 213.0345, found 213.0339
5-(Acridin-9-ylamino)uracil V-2
A mixture of 9-chloroacridine V-1 (0.5 g, 2.35 mmol) and phenol
(10.0 g, 0.11 mmol) was heated at 80 °C with stirring until phenol is
melted, 5-aminouracil (0.28 g, 2.2 mmol) was added and the mixture
was heated at 120 °C for 2 h. The reaction mixture was cooled to room temperature and
then was treated with dilute NH4OH (50 mL) to precipitate an orange solid. The crude
product was collected by filtration and was crystallized from ethanol to afford compound
V-2 (0.57 g, 85%).1H NMR (400 MHz, DMSO-d6) δ: 11.82 (bs, 1H), 11.24 (s, 1H), 10.87
(s, 1H), 8.27 (d, J = 8.0, 2H), 7.57 (t, J= 7.6, 2H), 7.65 (d, J = 8.0, 2H), 7.22 (t, J = 7.6,
2H);

13

C NMR: 177.5, 151.1, 141.5, 134.1, 131.9, 126.7, 121.7, 121.1, 117.9. HRMS

(EI): calcd. for C17H12N4O2 [M]+ 304.0960, found 304.0971.
Ethyl-2-(5-(acridin-9-ylamino)-uracil-1-yl)acetate V-3.
Compound V-2 (0.5 g, 1.64 mmol) was dissolved in dry DMF (8
mL), anhydrous K2CO3 (0.68 g, 4.92 mmol) was added and the
mixture was stirred on ice for 10 min followed by the dropwise
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addition of ethyl-2-bromoacetate (0.3 g, 1.8 mmol) over 30 min and the reaction mixture
was stirred for 24 h. The reaction mixture was filtered and the solvent was concentrated
under pressure to leave yellow oil. The oil was dissolved in dichloromethane (100 mL)
and was washed with saturated KHCO3 (2 x 50 mL), H2O (2 x 50 mL) and finally with
brine (2 x 50 mL). The organic phase was collected and dried over anhydrous Na2SO4,
filtered and concentrated in vacuo. The crude product was purified by flash
chromatography with hexane/ CH2Cl2 (8:2, v/v) to yield V-3 as yellow solid (0.42 g,
65%). 1H NMR (400 MHz, DMSO-d6)  : 11.42 (s, 1H), 10.97 (s, 1H), 8.25 (s, 1H), 7.94
(d, J = 7.5 Hz, 2H), 7.49 (d, J = 7.4 Hz, 7.5 2H), 7.31 (d, J = 7.5 Hz, 2H), 7.08 (t, J =
7.5 Hz, 2H), 4.51 (s, 2H), 4.16 (t, J =7.0 Hz, 2H), 1.20 (q, J = 7.0 Hz , 3H);

13

C NMR

(100 MHz, DMSO-d6)  ,177.4, 169.0, 161.9, 150.7, 150.0, 141.6, 134.1, 132.1, 126.7,
123.1, 121.6, 121.18, 117.9, 61.2, 49.2, 14.7. HRMS (EI) m/z: calcd. for C21H18 N4O4
[M+] 390.1328 found 390.1337.
2-(5-(Acridin-9-ylamino)-uracil-1-yl)acetic acid V-4.
The ethyl ester V-3 (0.35 g, 0.89 mmol) was dissolved in THF (25
mL) and was kept in an ice bath for 15 min followed by the
dropwise addition of NaOH (2.5 M, 5 mL) over 5 min with stirring.
The reaction mixture was removed from the ice bath and was
stirred at r.t. till completion of reaction. TLC analysis confirmed consumption of starting
material after 20 min. The reaction mixture was transferred to separatory funnel
containing KHSO4 (1.0 M, 50 mL) and dichloromethane (100 mL). The aqueous layer
was further extracted with dichloromethane (3 x 50 mL). The collected organics was
dried over anhydrous Na2SO4, filtered and concentrated in vacuo to afford the acid
derivative V-4 as orange solid (0.3 g, 93%). 1H NMR (400MHz, DMSO-d6)  : 13.39 (br
s, 1H), 11.93 (s, 1H), 11.01 (s, 1H), 8.67 (d, J = 8.6 Hz, 2H), 8.31 (s, 1H), 8.08 (d, J =
8.1 Hz, 2H), 7.99 (t, J = 8.1 Hz, 2H), 7.54 (t, J = 8.1 Hz, 2H) 4.59 (s, 2H);

13

C NMR

(DMSO-d6)  : 170.1, 161.4, 152.8, 150.9, 143.5, 134.7, 129.6, 125.0, 112.2, 49.8.
HRMS (ESI-TOF) m/z: calcd. for C19 H15 N4O4 [MH+] 363.1093 found 363.1108.
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tert-Butyl-2- N-(2-(9-fluorenylmethoxycarbonyl)aminoethyl)-2-(5-(acridin-9ylamino)-uracil-1-yl)acetamido)acetate V-5.
To a solution of V-4 (0.20 g, 0.552 mmol) in DMF (5 mL), N-[2(Fmoc)aminoethyl]glycine-t-butyl ester (0.20 g, 0.5 mmol), EDC
(0.11 g, 0.6 mmol), and HOBt (0.09 g, 0.6 mmol) was added and
the solution was stirred for 10 min at 4 °C and at r.t. for 24 h
under N2. The mixture was poured into iced water (25 mL) and the suspension was
placed at 4 °C for 2 h. The precipitated solid was collected by filtration, and was purified
by column chromato graphy using CH2Cl2 /MeOH (9.5: 0.5, v/v) as the eluent to give the
monomer ester V-5 (0.29 g, 71%) as an orange solid. Compound V-5 exists in solution as
a pair of slowly exchanging rotamers; signals attributed to major (ma.) and minor ( min.)
rotomers are designated : 1H NMR (400MHz, DMSO-d6)  : 10.9 (s, 1H), 10.5 (s, 1H),
8.24 (s, ma., 0.6H), 8.24 (s, mi., 0.4H), 7.89 (d, J = 7.4 Hz, 2H), 7.7 ( t, J = 8.2 Hz, 2H),
7.6 (t, 7.3, 2H), 7.5 (m, 4H), 7.43 (t, J = 7.4 Hz, 2H), 7.34 (t, J = 7.4 Hz, 2H), 7.25 (t, J =
7.8 Hz, 2H), 4.37 (s, 2H), 4.32 (d, J = 6.4 Hz, 2H), 4.26-420 (m, 4H), 4.14 (m, 1H), 3.91
(s, 1H), 3.24-18 (m, 2H), 1.42 (s, mi., 2H), 1.39 (s, ma., 7H);

13

C NMR (DMSO-d6) 

:176.8, 167.9, 166.5, 159.5, 156.4, 150.5, 143.9,143.8, 140.9, 133.4, 131.3, 127.6,
126.0,125.0, 121.0, 120.5, 120.1, 117.3, 115.3, 80.9, 65.5, 46.7, 42.0, 41.4, 27.6. HRMS
(EI) m/z: calcd. for C42H40N6O7 [M+ ] 740.2958 found 740.2943.
2-(N-(2-(9-Fluorenylmethoxycarbonyl)aminoethyl)-2-(5-(acridin-9-ylamino)-uracil1-yl)acetamido)acetic acid V-6.
To a suspension of compound V-5 (0.20 g, 0.27 mmol) in
dry CH2Cl2 (5 mL), Et3SiH (40 L, 0.2 mmol) was added
and cooled to 0 °C followed by dropwise addition of TFA (5
mL) and The reaction was stirred for 30 min on ice and an
additional 2 h at r.t. The mixture was evaporated to dryness by nitrogen stream’ the
remaining volatiles were removed by coevaporation with CH2Cl2 and diethyl ether. The
compound was dissolved in CH2Cl2 (3 mL), diethyl ether (50 mL) was added and cooled
to 0 °C overnight. The precipitated product was collected by filtration and was dried
under vacuum to obtain V-6 as orange solid (0.167 g, 90%). Compound V-6 exists in
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solution as a pair of slowly exchanging rotamers; signals attributed to major (ma.) and
minor (mi.) rotomers are designated : 1H NMR (400MHz, DMSO-d6)  : 11.77 ( br s,
1H), 11.45 (s, 1H), 10.77 (s, 1H), 8.61 (s, mi., 0.4H), 8.59 (s, ma., 0.6 H), 8.22 (d, J =
8.1, 1H), 8.06 (t, J = 6.2, 2H), 7.97 (d, J = 8.1,1H), 7.90 (d, J = 8.1, 3H), 7.73 ( t, J =
7.4,1H), 7.65 (m, 4H), 7.43 (t, J = 7.0, 2H), 7.33( t, J = 7.0, 2H), 4.41 (s, 2H), 4.33 (d, J =
6.4 Hz, 1H), ,4.29 (d, 2H), 4.26-4.16 (m, 3H), 3.89 (s, 1H), 3.22-19 (m, 2H). (HRMS
(ESI-TOF) m/z: calcd. for C38H33N6O7 [MH+] 685.2411 found 685.2441.
Quantum Yield determination
Fluorescence quantum yields (ΦF) of the acridine based monomer was determined using a
Photon Technologies International Quanta Master 7/2005 spectrophotometer by the
relative method30 using anthracene (ΦF = 0.32) as a reference standard. The quantum
yields were determined using emission wavelengths range between 370 and 600 nm with
an excitation wavelength of 360 nm.The quantum yield of the unknown Φ(x) can be
calculated by the following equation:
ΦF(x)= Φ(ST) (AST/AX) (FX/FST) (η2X/η2ST)
Where Φ(ST) is the quantum yield of the standard, A is the absorbance at the excitation
wavelength, F is the integrated area in the emission curve, the subscripts X and ST refer
to unknown and standard respectively and η is the refractive index of the solvent. By
measuring a series of diluted solutions with various absorbance readings the following
equation may be used:
ΦF(x)= Φ(ST) (GradX/GradST) (η2X/η2ST)
Where Grad is the gradient from the plot of integrated area in the emission curve versus
absorbance at the excitation wavelength. The validity of the methodology was confirmed
by measuring these characterized compounds: anthracene (ΦF = 0.29, in ethanol),31
dichloroanthracene (ΦF = 0.58, in ethanol)30 and 9,10-Diphenylanthracene (DPA) (ΦF =
0.95 in ethanol),32 and gave the following values 0.27, 0.56, 0.91 that are in very good
agreement with the literature values.
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6

Future Outlook

We have achieved the synthesis of a PNA monomer bearing the 4-(N,Ndimethylamino)azobenzene

unit

as

a

nucleobase

successfully incorporated into an 8-mer PNA oligomer.

replacement

and

have

Furthermore, we have

demonstrated the utility of the 4-(N,N-dimethylamino)azobenzene unit to act as a
quencher in a PNA-molecular beacon (PNA-MB) design utilizing fluorescein as the
luminophore. The 4-(N,N-dimethylamino)azobenzene showed high quenching ability
upon hybridization of the PNA-MB to the complementary deoxynucleic acid. Signalling
of the hybridization event occurred by recovery of the fluorescence emission of
fluorescein by over 100 fold.

The presence of an azobenzene unit in PNA oligomer caused an increase in the stability
of the triplex structure formed between 2PNA containing thymine residues with the
complementary DNA. These results encourage us to investigate the quenching ability,
photoresponse and stability effect of some azobenzene derivatives with large fused ring
systems such as phenanthrenyl and anthracenyl phenylazo derivatives as shown in (Fig.
6-1). These modifications may lead to increase the quenching range and stabilizing effect
on the hybrid formed due to the good intercalation of the phenylazo derivatives into the
helical structure.

Figure 6-1: Stuctures of phenylazo derivatives.
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We have also synthesized a modified uracil by introduction of phenylazo moiety at C5 to
yield a uracil analogue that showed intrinsic quenching ability. A PNA monomer
possessing the modified uracil was synthesized and it showed quenching ability to
quench fluorescein emission in a short FRET-peptide design that was used as substrate
for Cathepsin D enzyme. The advantage of this modification is that it provides the
possibility to attach the modified azo-uracil at any position of the designed PNA
oligomer and therefore may lead to increase the stability of the formed hybrid compared
to the traditional azobenzene due to retaining its hydrogen bonding ability.

In addition, we aimed to introduce the azo-based uracil into DNA and RNA chemistry by
formation of the corresponding phosphoramidites. Formation of DNA and RNA
molecular beacon containing the azo-modified uracil may show quenching ability.
Incorporation of several azo-modifed uracil units into DNA may result in
a photoresponsive oligomer, that is, the ability to photoregulate duplex formation with
a complementary nucleic acid sequence through irradiation with light of a specific
wavelength.

Incorporation of the modified azo-based uracil PNA monomer into PNA oligomer is
underway to assess its ability to photoregulate the duplex structure that obtained with the
complementary nucleic acid. We will investigate the effect of extending the ring size of
phenylazo moiety on the quenching ability of the modified uracil as shown in (Fig.6-2).

Figure 6-2: Structures of azo-based uracil derivatives.
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